<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">62718</article-id><article-id pub-id-type="doi">10.7554/eLife.62718</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Multiple pathways of toxicity induced by <italic>C9orf72</italic> dipeptide repeat aggregates and G<sub>4</sub>C<sub>2</sub> RNA in a cellular model</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-206993"><name><surname>Frottin</surname><given-names>Frédéric</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2756-7838</contrib-id><email>frederic.frottin@i2bc.paris-saclay.fr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-206994"><name><surname>Pérez-Berlanga</surname><given-names>Manuela</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9064-9724</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-8111"><name><surname>Hartl</surname><given-names>F Ulrich</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7941-135X</contrib-id><email>uhartl@biochem.mpg.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-205241"><name><surname>Hipp</surname><given-names>Mark S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0497-3016</contrib-id><email>m.s.hipp@umcg.nl</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Max Planck Institute of Biochemistry</institution><addr-line><named-content content-type="city">Martinsried</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC)</institution><addr-line><named-content content-type="city">Gif-sur-Yvette</named-content></addr-line><country>France</country></aff><aff id="aff3"><label>3</label><institution>Department of Quantitative Biomedicine, University of Zurich</institution><addr-line><named-content content-type="city">Zurich</named-content></addr-line><country>Switzerland</country></aff><aff id="aff4"><label>4</label><institution>Department of Biomedical Sciences of Cells and Systems, University Medical Center Groningen, University of Groningen</institution><addr-line><named-content content-type="city">Groningen</named-content></addr-line><country>Netherlands</country></aff><aff id="aff5"><label>5</label><institution>School of Medicine and Health Sciences, Carl von Ossietzky University Oldenburg</institution><addr-line><named-content content-type="city">Oldenburg</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ackerman</surname><given-names>Susan L</given-names></name><role>Reviewing Editor</role><aff><institution>Howard Hughes Medical Institute, University of California, San Diego</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Ron</surname><given-names>David</given-names></name><role>Senior Editor</role><aff><institution>University of Cambridge</institution><country>United Kingdom</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>23</day><month>06</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e62718</elocation-id><history><date date-type="received" iso-8601-date="2020-09-02"><day>02</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-06-08"><day>08</day><month>06</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Frottin et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Frottin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-62718-v1.pdf"/><abstract><p>The most frequent genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia is a G<sub>4</sub>C<sub>2</sub> repeat expansion in the <italic>C9orf72</italic> gene. This expansion gives rise to translation of aggregating dipeptide repeat (DPR) proteins, including poly-GA as the most abundant species. However, gain of toxic function effects have been attributed to either the DPRs or the pathological G<sub>4</sub>C<sub>2</sub> RNA. Here, we analyzed in a cellular model the relative toxicity of DPRs and RNA. Cytoplasmic poly-GA aggregates, generated in the absence of G<sub>4</sub>C<sub>2</sub> RNA, interfered with nucleocytoplasmic protein transport, but had little effect on cell viability. In contrast, nuclear poly-GA was more toxic, impairing nucleolar protein quality control and protein biosynthesis. Production of the G<sub>4</sub>C<sub>2</sub> RNA strongly reduced viability independent of DPR translation and caused pronounced inhibition of nuclear mRNA export and protein biogenesis. Thus, while the toxic effects of G<sub>4</sub>C<sub>2</sub> RNA predominate in the cellular model used, DPRs exert additive effects that may contribute to pathology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>quality control</kwd><kwd>protein aggregation</kwd><kwd>neurodegeneration</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003043</institution-id><institution>EMBO</institution></institution-wrap></funding-source><award-id>Long term fellowship</award-id><principal-award-recipient><name><surname>Frottin</surname><given-names>Frédéric</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000780</institution-id><institution>European Commission</institution></institution-wrap></funding-source><award-id>FP7 GA ERC-2012-SyG_318987-ToPAG</award-id><principal-award-recipient><name><surname>Hartl</surname><given-names>F Ulrich</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Federal Ministry of Education and Research</institution></institution-wrap></funding-source><award-id>01PL17016</award-id><principal-award-recipient><name><surname>Pérez-Berlanga</surname><given-names>Manuela</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004189</institution-id><institution>Max Planck Society</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Hipp</surname><given-names>Mark S</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Protein aggregates resulting from mutations in <italic>C9orf72</italic> impair different aspects of cellular quality control in the cytosol and the nucleus, but mRNA-mediated effects contribute more strongly to toxicity.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Expansion of a GGGGCC hexanucleotide repeat (hereafter G<sub>4</sub>C<sub>2</sub>) within the first intron of the <italic>C9orf72</italic> gene is the most frequent genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) (<xref ref-type="bibr" rid="bib18">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Renton et al., 2011</xref>). Mutant <italic>C9orf72</italic> in patients suffering from ALS/FTD can have more than a thousand G<sub>4</sub>C<sub>2</sub> repeats, while healthy individuals possess usually less than 20 repeats (<xref ref-type="bibr" rid="bib27">Gijselinck et al., 2016</xref>; <xref ref-type="bibr" rid="bib57">Nordin et al., 2015</xref>). Transcripts with expanded G<sub>4</sub>C<sub>2</sub> tracts are translated by repeat associated non-AUG (RAN) translation in all reading frames and in both strands, resulting in the synthesis of five different dipeptide repeat proteins (DPRs): poly-GA, poly-GR, poly-GP, poly-PR, and poly-PA (<xref ref-type="bibr" rid="bib4">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Gendron et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib52">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib103">Zu et al., 2013</xref>), all of which have been detected in patient brains (<xref ref-type="bibr" rid="bib52">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib103">Zu et al., 2013</xref>). Poly-GA is the most abundant of the DPRs, followed by the other sense strand-encoded forms (poly-GP and poly-GR) (<xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>). In patient brain and cellular models, DPRs accumulate in deposits that can be found in the nucleus and cytoplasm, including neurites (<xref ref-type="bibr" rid="bib4">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Gendron et al., 2013</xref>; <xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib52">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>; <xref ref-type="bibr" rid="bib103">Zu et al., 2013</xref>). Poly-GA aggregates are localized mainly in the cytoplasm (<xref ref-type="bibr" rid="bib17">Davidson et al., 2016</xref>; <xref ref-type="bibr" rid="bib45">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib99">Zhang et al., 2016</xref>), whereas arginine-containing DPRs (R-DPRs; poly-GR and poly-PR) accumulate in the nucleus (<xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>). R-DPRs have also been shown in cellular models to localize to the nucleolus (<xref ref-type="bibr" rid="bib42">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib45">Lee et al., 2017</xref>; <xref ref-type="bibr" rid="bib49">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib51">Moens et al., 2019</xref>; <xref ref-type="bibr" rid="bib88">Wen et al., 2014</xref>; <xref ref-type="bibr" rid="bib91">White et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Yamakawa et al., 2015</xref>; <xref ref-type="bibr" rid="bib97">Zhang et al., 2014</xref>). However, in patients, poly-GR and poly-PR predominantly form cytoplasmic deposits, with only a fraction of cells containing para-nucleolar inclusions that co-localize with silent DNA (<xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>). Interestingly, the less frequent intranuclear poly-GA inclusions in both cell models and patient brain are excluded from the nucleoli (<xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>).</p><p>Both loss- and gain-of-function mechanisms have been suggested to contribute to <italic>C9orf72</italic> pathology (reviewed in <xref ref-type="bibr" rid="bib6">Balendra and Isaacs, 2018</xref>; <xref ref-type="bibr" rid="bib34">Jiang and Ravits, 2019</xref>; <xref ref-type="bibr" rid="bib80">Swinnen et al., 2018</xref>). Despite its location in a non-coding part of the gene, the G<sub>4</sub>C<sub>2</sub> expansion can alter the expression level of the C9ORF72 protein (<xref ref-type="bibr" rid="bib65">Rizzu et al., 2016</xref>; <xref ref-type="bibr" rid="bib73">Shi et al., 2018</xref>; <xref ref-type="bibr" rid="bib86">Waite et al., 2014</xref>). However, <italic>C9orf72</italic> knockout mouse models failed to fully recapitulate ALS- or FTD-related neurodegenerative phenotypes, suggesting that loss of C9ORF72 protein is not the only contributor to pathology (<xref ref-type="bibr" rid="bib5">Atanasio et al., 2016</xref>; <xref ref-type="bibr" rid="bib10">Burberry et al., 2016</xref>; <xref ref-type="bibr" rid="bib11">Burberry et al., 2020</xref>; <xref ref-type="bibr" rid="bib33">Jiang et al., 2016</xref>; <xref ref-type="bibr" rid="bib40">Koppers et al., 2015</xref>; <xref ref-type="bibr" rid="bib43">Lagier-Tourenne et al., 2013</xref>; <xref ref-type="bibr" rid="bib58">O'Rourke et al., 2016</xref>; <xref ref-type="bibr" rid="bib60">Panda et al., 2013</xref>; <xref ref-type="bibr" rid="bib77">Sudria-Lopez et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Sullivan et al., 2016</xref>; <xref ref-type="bibr" rid="bib79">Suzuki et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Ugolino et al., 2016</xref>; <xref ref-type="bibr" rid="bib102">Zhu et al., 2020</xref>).</p><p>Toxic functions induced by the G<sub>4</sub>C<sub>2</sub> expansion have been studied in various cellular and animal models, and both RNA- and protein-based mechanisms of toxicity have been proposed (<xref ref-type="bibr" rid="bib3">Arzberger et al., 2018</xref>). However, the main contributor to gain of toxic function in the disease remains to be defined. Pathological G<sub>4</sub>C<sub>2</sub> mRNA forms stable G-quadruplexes in the nucleus that retain RNA binding proteins and induce splicing defects (<xref ref-type="bibr" rid="bib15">Cooper-Knock et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Donnelly et al., 2013</xref>; <xref ref-type="bibr" rid="bib28">Gitler and Tsuiji, 2016</xref>; <xref ref-type="bibr" rid="bib31">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib67">Sareen et al., 2013</xref>; <xref ref-type="bibr" rid="bib74">Simón-Sánchez et al., 2012</xref>; <xref ref-type="bibr" rid="bib94">Xu et al., 2013</xref>), but has also been observed in the cytoplasm (<xref ref-type="bibr" rid="bib16">Cooper-Knock et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Mizielinska et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">Ohki et al., 2017</xref>; <xref ref-type="bibr" rid="bib80">Swinnen et al., 2018</xref>). G<sub>4</sub>C<sub>2</sub>-containing RNA and associated DPRs have been reported to alter the nucleocytoplasmic transport machinery (<xref ref-type="bibr" rid="bib7">Boeynaems et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib98">Zhang et al., 2015</xref>). Moreover, R-DPRs can interact with membrane-free phase-separated compartments, such as the nucleolus, causing nucleolar stress and dysfunction of nucleolar quality control, impairment of nucleocytoplasmic trafficking and protein translation, as well as induction of stress granule formation (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib32">Hayes et al., 2020</xref>; <xref ref-type="bibr" rid="bib36">Kanekura et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Mizielinska et al., 2017</xref>; <xref ref-type="bibr" rid="bib51">Moens et al., 2019</xref>; <xref ref-type="bibr" rid="bib61">Radwan et al., 2020</xref>; <xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>; <xref ref-type="bibr" rid="bib81">Tao et al., 2015</xref>; <xref ref-type="bibr" rid="bib84">Vanneste et al., 2019</xref>; <xref ref-type="bibr" rid="bib91">White et al., 2019</xref>; <xref ref-type="bibr" rid="bib95">Yamakawa et al., 2015</xref>; <xref ref-type="bibr" rid="bib101">Zhang et al., 2018b</xref>). Additionally, cytoplasmic poly-GA aggregates associate extensively with proteasomes and other components of the ubiquitin proteasome system, and interfere with proteasome activity (<xref ref-type="bibr" rid="bib1">Al-Sarraj et al., 2011</xref>; <xref ref-type="bibr" rid="bib30">Guo et al., 2018</xref>; <xref ref-type="bibr" rid="bib39">Khosravi et al., 2020</xref>; <xref ref-type="bibr" rid="bib49">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib64">Riemslagh et al., 2019</xref>), as well as induce mislocalization of nuclear proteins (<xref ref-type="bibr" rid="bib38">Khosravi et al., 2017</xref>; <xref ref-type="bibr" rid="bib55">Nihei et al., 2020</xref>; <xref ref-type="bibr" rid="bib56">Nonaka et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Solomon et al., 2018</xref>). In mice expressing poly-GA, the aggregates have also been observed to sequester nuclear pore components (<xref ref-type="bibr" rid="bib99">Zhang et al., 2016</xref>), thereby interfering with nucleocytoplasmic protein transport. In light of these studies, it seems likely that multiple toxicity mechanisms contribute to pathogenesis (<xref ref-type="bibr" rid="bib6">Balendra and Isaacs, 2018</xref>).</p><p>Here, we used G<sub>4</sub>C<sub>2</sub> repeat-containing constructs as well as synthetic DPR constructs not generating G<sub>4</sub>C<sub>2</sub> RNA to analyze the relative contributions of RNA and DPR species to pathology in a cellular model. The mRNA and protein constructs analyzed were of equivalent length. By retaining DPR proteins in the cytoplasm or targeting them to the nucleus, we found that cytoplasmic, but not nuclear poly-GA, aggregates impaired nucleocytoplasmic transport. However, a direct comparison of length-matched constructs showed that nuclear poly-GA was more toxic and interfered with nucleolar protein quality control and protein synthesis. Importantly, by leveraging the finding that cytoplasmic poly-GA does not induce toxicity in the cellular model system, we were able to isolate the contribution of the G<sub>4</sub>C<sub>2</sub> repeat RNA to cellular pathology. The G<sub>4</sub>C<sub>2</sub>-containing RNA species induced a strong accumulation of poly-adenylated mRNA within the nucleus and dramatically inhibited protein biosynthesis. Thus, poly-GA protein and G<sub>4</sub>C<sub>2</sub> RNA interfere with multiple key cellular pathways, with the RNA component exerting the major toxic effects limiting cell viability.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Nuclear and cytoplasmic poly-GA aggregates differ in toxicity</title><p>Both G<sub>4</sub>C<sub>2</sub> RNA and DPR proteins resulting from the pathological <italic>C9orf72</italic> expansion have been suggested to mediate gain of toxic function effects in various models (reviewed in <xref ref-type="bibr" rid="bib6">Balendra and Isaacs, 2018</xref>). To investigate the contribution of poly-GA proteins to cellular pathology, we engineered ATG-driven synthetic constructs expressing 65 GA repeats fused C-terminally to GFP (GA<sub>65</sub>-GFP). Notably, these constructs do not contain any G<sub>4</sub>C<sub>2</sub> hexanucleotide motifs (<xref ref-type="fig" rid="fig1">Figure 1A,</xref> <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Cytoplasmic and nuclear poly-GA aggregates are amyloid-like but differ in solubility.</title><p>(<bold>A</bold>) Schematic representation of the poly-GA encoding constructs used. Two different classes of poly-GA encoding constructs were used to study dipeptide repeat protein (DPR)-mediated toxicity in the presence or absence of RNA repeat regions: synthetic constructs that do not contain G<sub>4</sub>C<sub>2</sub> motifs and are translated into GA<sub>65</sub> (left), and constructs containing 73 G<sub>4</sub>C<sub>2</sub> repeats that encode GA<sub>73</sub> (right). Both classes contained ATG start codons and were fused in frame to GFP. N-terminal nuclear import (NLS) or export sequences (NES) were present when indicated. (<bold>B</bold>) The indicated constructs were transfected into HEK293 cells. Antibodies against nuclear pore complexes (NPC, red) were used to detect the nuclear membrane, poly-GA was visualized by GFP fluorescence (green), and nuclei were counterstained with DAPI. (<bold>C</bold>) NES-GA<sub>65</sub>-GFP aggregates co-localize with p62. The indicated constructs were transfected into HEK293 cells. p62 (red) was detected by immunofluorescence, and poly-GA was visualized by GFP fluorescence (green). White dashed lines delineate the nucleus based on DAPI staining. (<bold>D</bold>) Cytoplasmic and nuclear aggregates can be stained with an amyloid-specific dye. The indicated constructs were transfected into HEK293 cells and stained with AmyTracker (AmyT, red). Poly-GA DPRs were visualized by GFP fluorescence (green). White dashed lines delineate the nucleus based on DAPI staining. (<bold>E</bold>) Cytoplasmic GA aggregates are SDS insoluble. The indicated constructs were transfected into HEK293 cells. GFP was expressed as a soluble control protein. Cells were lysed and analyzed for SDS-insoluble poly-GA aggregates by filter retardation assay. GFP antibody was used for detection. Scale bars represent 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Cytoplasmic and nuclear poly-GA aggregates differ in their staining properties.</title><p>(<bold>A</bold>) Sequences of the GA-expressing constructs used in this study. Sequences (1) and (2) are synthetic degenerated sequences that do not contain G<sub>4</sub>C<sub>2</sub>. A third construct only contains G<sub>4</sub>C<sub>2</sub> repeats and is translated into GA<sub>73</sub>. All three constructs contain an ATG start codon in frame with the GA coding sequence. (<bold>B</bold>) Cytoplasmic and nuclear aggregates can be stained with the OC antibody against amyloid fibrils. GA<sub>65</sub>-GFP was expressed in HEK293 cells, and immunofluorescence analysis was performed against amyloid fibrils (OC, red). Poly-GA was visualized by GFP fluorescence (green). White dashed lines delineate the nucleus based on DAPI staining. Scale bar represents 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Expression of GA<sub>65</sub>-GFP in HEK293 cells resulted in the formation of bright fluorescent inclusions in most transfected cells. The inclusions were generally cytoplasmic, except for a small fraction of cells with nuclear foci (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). This phenotype is consistent with reports on the localization of poly-GA aggregates in patient brain, where poly-GA aggregates are also observed in the neuronal cytoplasm and nucleus (<xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>). Using engineered β-sheet proteins, we have previously reported that otherwise identical aggregation-prone proteins display distinct toxic properties when targeted to different cellular compartments (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib85">Vincenz-Donnelly et al., 2018</xref>; <xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). To test whether this is also the case for poly-GA, we generated compartment-specific variants of the poly-GA proteins. We restricted the expression of poly-GA to the cytoplasm by adding a nuclear export signal (NES-GA<sub>65</sub>-GFP) or targeted the protein to the nucleus using a double SV40 nuclear localization signal (NLS-GA<sub>65</sub>-GFP). NES-GA<sub>65</sub>-GFP accumulated in the cytoplasm and formed inclusions similar to those of GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). Directing the protein to the nucleus resulted in an increased number of cells with nuclear aggregates (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). However, a number of NLS-GA<sub>65</sub>-GFP-expressing cells also contained cytoplasmic inclusions, suggesting that aggregate formation in these cells occurred before the transport of the poly-GA proteins into the nucleus.</p><p>Poly-GA forms p62-positive inclusions in the cytoplasm of neurons (<xref ref-type="bibr" rid="bib30">Guo et al., 2018</xref>). We were able to replicate this phenotype in our cellular system and observed p62-positive poly-GA inclusions of GA<sub>65</sub>-GFP and NES-GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig1">Figure 1C</xref>; <xref ref-type="bibr" rid="bib49">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>). Both nuclear and cytoplasmic poly-GA inclusions were stained throughout with AmyT, a small amyloid-specific dye (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). The aggregates were also recognized by the anti-amyloid antibody (OC) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>), which recognizes generic epitopes common to amyloid fibrils and fibrillar oligomers (<xref ref-type="bibr" rid="bib37">Kayed et al., 2007</xref>). However, while the nuclear aggregates stained homogeneously with OC, cytoplasmic GA<sub>65</sub>-GFP inclusions stained less well and rather showed only a peripheral reaction with the dye (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). The differential antibody accessibility of the inclusion core suggests that the nuclear and cytoplasmic DPR aggregates, though both amyloid-like, differ in structural properties such as packing density.</p><p>Analysis of the solubility of the nuclear and cytoplasmic GA<sub>65</sub>-GFP aggregates supported this interpretation. NES-GA<sub>65</sub>-GFP was retained in a filter retardation assay in the presence of SDS, while most NLS-GA<sub>65</sub>-GFP passed through the filter (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). The difference in detergent solubility was not due to the presence of the NLS sequence since similar results were obtained using the FUS-derived C-terminal nuclear localization signal (PY) (<xref ref-type="bibr" rid="bib24">Gal et al., 2011</xref>; <xref ref-type="fig" rid="fig1">Figure 1E</xref>). Moreover, disabling of the nuclear targeting sequences by point mutations resulted in the reappearance of SDS-insoluble aggregates (<xref ref-type="fig" rid="fig1">Figure 1E</xref>). Thus, despite being amyloid-like, nuclear and cytoplasmic poly-GA aggregates have different physico-chemical properties.</p><p>The granular component (GC) of the nucleolus has recently been shown to function as a protein quality control compartment (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Interestingly, the nuclear aggregates of NLS-GA<sub>65</sub>-GFP altered the localization of the GC marker protein nucleophosmin (NPM1), while cytosolic NES-GA<sub>65</sub>-GFP had no such effect (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Nuclear GA<sub>65</sub>-GFP aggregates induced the dislocation of NPM1 from the GC phase of the nucleolus, with accumulation of NPM1 at the aggregate periphery (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). However, the nuclear GA<sub>65</sub>-GFP deposits did not alter the distribution of the RNA polymerase I subunit RPA40, a marker of the fibrillar center of the nucleolus, the site of rRNA synthesis (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). The NPM1-containing GC phase is responsible for pre-ribosome particle assembly and also accommodates proteins that have misfolded upon stress. These proteins enter the GC phase and are maintained in a state competent for refolding and repartitioning to the nucleoplasm upon recovery from stress (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>). In contrast to poly-GA, R-DPRs enter the GC phase of the nucleolus and convert it from liquid-like to a more hardened state, thereby impairing its quality control function (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2016</xref>). To test whether nuclear poly-GA aggregates also affect nucleolar quality control, we expressed the synthetic poly-GA constructs in HEK293 cells together with nuclear firefly luciferase fused to the red fluorescent protein mScarlet (NLS-LS), a metastable protein that enters the GC phase upon stress-induced misfolding (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>). In control cells, NLS-LS accumulated in the nucleolus upon heat stress and largely repartitioned to the nucleoplasm within 2 hr of recovery (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). A similar result was obtained upon expression of cytoplasmic NES-GA<sub>65</sub>-GFP. However, in the presence of aggregates of NLS-GA<sub>65</sub>-GFP, NLS-LS failed to efficiently repartition to the nucleoplasm (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), indicating that the nuclear poly-GA aggregates compromise nucleolar protein quality control.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Nuclear poly-GA aggregates compromise nucleolar integrity and impair cell viability.</title><p>(<bold>A</bold>) Nuclear poly-GA aggregates alter nucleophosmin (NPM1) localization. The indicated constructs were transfected into HEK293 cells. Cells were fixed and stained with anti-NPM1 antibodies (red). Poly-GA was visualized by GFP fluorescence (green). (<bold>B</bold>) Nuclear poly-GA aggregates are not nucleolar. The indicated constructs were transfected into HEK293 cells, followed by staining with antibodies against DNA-directed RNA polymerases I and III subunit RPAC1 (RPA40) (red). Poly-GA was visualized by GFP fluorescence (green). (<bold>C</bold>) Nuclear poly-GA aggregates disrupt nucleolar protein quality control. HEK293 cells were co-transfected with NLS-firefly luciferase fused to mScarlet (NLS-LS) and the indicated poly-GA constructs or GFP as a control. Cells were maintained at 37°C (–HS) or subjected to heat stress 43°C (+HS) for 2 hr or heat stress and recovery (+HS + Rec) for 1 hr and 2 hr. Cells with nucleolar NLS-LS were counted, and the results plotted as percentage of transfected cells. Data are shown as mean + SD (n = 3). p-Value of two-sided t-test is displayed (***p≤0.001). Representative immunofluorescence images are shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>. (<bold>D</bold>) Nuclear poly-GA is toxic. HEK293 cells were transfected with the indicated constructs, and MTT cell viability assays were performed 4 days after transfection. Data were normalized to cells transfected with empty vector. Data are shown as means + SD (n ≥ 3); p-values of two-sided t-test are shown (***p≤0.001). White dashed lines delineate the nucleus based on DAPI staining. Scale bars represent 10 µm.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig2">Figure 2C</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig2-data1-v1.docx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig2">Figure 2D</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig2-data2-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Nuclear poly-GA aggregates impair nucleolar protein quality control and cell viability.</title><p>(<bold>A</bold>) Nuclear poly-GA aggregates disrupt nucleolar protein quality control. HEK293 cells were co-transfected with NLS-LS and the indicated poly-GA (NLS-GA<sub>65</sub>-GFP or NES-GA<sub>65</sub>-GFP) constructs or GFP as control. Cells were maintained at 37°C (–HS) or subjected to heat stress at 43°C for 2 hr (+HS) and recovery (+HS + Rec) for 2 hr. Samples were immunostained for NPM1 (cyan), and NLS-LS and poly-GA proteins were visualized by mScarlet and GFP fluorescence, respectively. Merged panels are shown, and a white dashed line delineates the nucleus based on DAPI staining. Scale bars represent 10 µm. Representative images of three independent experiments are shown. See <xref ref-type="fig" rid="fig2">Figure 2C</xref> for quantification. (<bold>B</bold>) NLS-GA<sub>65</sub>-GFP produced from an alternative degenerated and G<sub>4</sub>C<sub>2</sub>-free DNA sequence also decreases cellular viability. HEK293 cells were transfected with the indicated constructs, and MTT cell viability assays performed 4 days after transfection. Data were normalized to cells transfected with empty vector. Data are means + SD (n ≥ 3), and two-sided t-test is shown (***p≤0.001). β23 data are from <xref ref-type="fig" rid="fig2">Figure 2D</xref> and are shown as control. (<bold>C</bold>) Disabling nuclear targeting sequence functionality of GA<sub>65</sub>-GFP rescues cellular viability. HEK293 cells were transfected with constructs encoding two different nuclear localization sequences (NLS or PY) fused to GFP, GA<sub>65</sub>-GFP, or GA<sub>65</sub>-GFP with an inactivating mutation in the nuclear localization sequence (MutLS-GA<sub>65</sub>-GFP), followed by MTT cell viability assay 4 days after transfection. Data were normalized to cells transfected with empty vector. Data are shown as means + SD (n ≥ 3). ***p≤0.001 by two-sided t-test. Part of this data is also shown in <xref ref-type="fig" rid="fig2">Figure 2D</xref>. (<bold>D</bold>) HEK293 cells were transfected with the indicated constructs (GA<sub>65</sub>-GFP; NES-GA<sub>65</sub>-GFP; NES-GA<sub>65</sub>(2)-GFP; NLS-GA<sub>65</sub>-GFP; and NLS-GA<sub>65</sub>(2)-GFP). Expression levels were determined by immunoblotting with anti-GFP antibodies, α-tubulin served as loading control.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig2-figsupp1-v1.tif"/></fig></fig-group><p>We next analyzed the viability of HEK293 cells expressing poly-GA in cytoplasm or nucleus. We used the MTT assay to measure metabolic activity, which reflects not only cytotoxic effects but also changes in cell division and overall cellular fitness. Cytoplasmic and nuclear forms of an amyloidogenic model protein without repeat sequences (β23) served as a control (<xref ref-type="bibr" rid="bib89">West et al., 1999</xref>; <xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). While the expression of NES-GA<sub>65</sub>-GFP did not cause toxicity, metabolic activity was significantly reduced upon expression of NLS-GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). This effect was reproduced in cells transfected with a plasmid coding for GA<sub>65</sub> from an alternative degenerated and G<sub>4</sub>C<sub>2</sub>-free DNA sequence (GA<sub>65</sub>(2)) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>), further excluding RNA-mediated toxicity. Decreased viability was also observed when GA<sub>65</sub>-GFP was targeted to the nucleus via the alternative PY localization signal (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Importantly, both NES-GA<sub>65</sub>-GFP and NLS-GA<sub>65</sub>-GFP were expressed at levels comparable to GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1D</xref>). Point mutations in the NLS or PY targeting sequence prevented accumulation of GA<sub>65</sub>-GFP in the nucleus and restored viability (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C</xref>). Together, these results indicate that the difference in toxicity between nuclear and cytoplasmic poly-GA is caused by compartment-specific properties of the aggregates independent of their targeting sequences and mRNA.</p></sec><sec id="s2-2"><title>Cytoplasmic GA<sub>65</sub>-GFP aggregates interfere with nuclear transport</title><p>We have previously shown that artificial β-sheet proteins, when aggregating in the cytoplasm, sequester nuclear transport factors and thereby interfere with transport of proteins and mRNA across the nuclear envelope (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Similar observations were made for the aggregates of various disease proteins including poly-GA and R-DPRs (<xref ref-type="bibr" rid="bib7">Boeynaems et al., 2016</xref>; <xref ref-type="bibr" rid="bib13">Chou et al., 2018</xref>; <xref ref-type="bibr" rid="bib21">Eftekharzadeh et al., 2019</xref>; <xref ref-type="bibr" rid="bib22">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib25">Gasset-Rosa et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Grima et al., 2017</xref>; <xref ref-type="bibr" rid="bib35">Jovičić et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Khosravi et al., 2017</xref>; <xref ref-type="bibr" rid="bib41">Kramer et al., 2018</xref>; <xref ref-type="bibr" rid="bib76">Solomon et al., 2018</xref>; <xref ref-type="bibr" rid="bib98">Zhang et al., 2015</xref>; <xref ref-type="bibr" rid="bib99">Zhang et al., 2016</xref>). To test which role the localization of the poly-GA proteins plays in this process, we expressed NES-GA<sub>65</sub>-GFP or NLS-GA<sub>65</sub>-GFP together with the reporter protein shuttle-mApple (S-mApple). This reporter protein contains both nuclear import and export signals and consequently shuttles between nucleus and cytoplasm. At steady state, S-mApple localized mainly to the cytoplasm, but accumulated within minutes in the nucleus upon inhibition of nuclear export with leptomycin B (LMB) (<xref ref-type="bibr" rid="bib93">Wolff et al., 1997</xref>; <xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Cytoplasmic poly-GA aggregates impair nucleocytoplasmic protein transport.</title><p>(<bold>A</bold>) Cytoplasmic poly-GA aggregates alter nuclear transport of a shuttling reporter protein. HEK293 cells were co-transfected with S-mApple (red) and either empty vector (Control), NES-β17, NES-GA<sub>65</sub>-GFP, NLS-β17, NLS-GA<sub>65</sub>-GFP, GA<sub>65</sub>-GFP, or GA<sub>65</sub>-GFP-PY (green). Leptomycin B (LMB; 10 ng/ml) was added for 15 min when indicated. White dashed lines delineate nuclei based on DAPI staining. Scale bar represents 10 µm. (<bold>B</bold>) Quantification of S-mApple distribution from data in (<bold>A</bold>). The x-axis shows the enrichment of S-mApple concentration in the cytoplasm relative to the nucleus. Cells transfected with GA<sub>65</sub>-GFP were further analyzed and divided into cells with cytoplasmic (Cyt) or nuclear (Nuc) aggregates. Data are means + SD, n = 3 independent experiments, &gt;70 cells were analyzed per condition. *p≤0.05 from two-sided t-test.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig3">Figure 3B</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig3-data1-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig3-v1.tif"/></fig><p>As previously described, S-mApple was retained within the nucleus upon expression of the cytoplasmic β-sheet protein NES-β17 (<xref ref-type="fig" rid="fig3">Figure 3</xref>), indicative of inhibition of nuclear protein export (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Expression of NES-GA<sub>65</sub>-GFP also impaired S-mApple export from the nucleus (-LMB), but to a lesser extent than NES-β17 (<xref ref-type="fig" rid="fig3">Figure 3</xref>). A mild impairment of nuclear protein import by NES-GA<sub>65</sub>-GFP was also observed, as measured upon inhibition of export with LMB (<xref ref-type="fig" rid="fig3">Figure 3</xref>). As for NLS-β17, nuclear poly-GA aggregates had only a weak effect on protein export (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Similarly, cells containing nuclear aggregates did not show a significant change in S-mApple import into the nucleus (<xref ref-type="fig" rid="fig3">Figure 3</xref>). These findings were replicated in cells displaying cytoplasmic or nuclear poly-GA aggregates of untargeted GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig3">Figure 3</xref>).</p><p>We next monitored the nuclear translocation of p65, a subunit of the NF-ĸB complex, upon stimulation by the cytokine TNFα. In control cells, p65 is largely cytoplasmic and enters the nucleus upon treatment with TNFα (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). Cells containing NES-GA<sub>65</sub>-GFP aggregates displayed a potent inhibition of p65 translocation (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). A similar effect was seen with cytoplasmic aggregates of polyQ-expanded Huntingtin-exon 1 (Htt96Q) as a positive control (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>; <xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Cells containing cytoplasmic aggregates of untargeted GA<sub>65</sub>-GFP also displayed reduced p65 translocation (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>). The observed translocation impairment was independent of an alteration of p65 phosphorylation and degradation of the inhibitor of nuclear factor κB (IκB) (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). In contrast, nuclear poly-GA aggregates showed only a limited effect on p65 translocation (<xref ref-type="fig" rid="fig4">Figure 4A, B</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Cytoplasmic poly-GA aggregates inhibit nuclear import of p65.</title><p>(<bold>A</bold>) Cytoplasmic poly-GA aggregates inhibit p65 nuclear translocation. HEK293 cells were transfected with empty vector (Control), NES-GA<sub>65</sub>-GFP, NLS-GA<sub>65</sub>-GFP, GA<sub>65</sub>-GFP, GA65-GFP-PY, or Htt96Q-GFP (Htt96Q) (green) and analyzed for NF-κB p65 localization (red) with and without TNFα treatment (30 min). White dashed lines delineate nuclei based on DAPI staining. Scale bar represents 10 µm. (<bold>B</bold>) Quantification of NF-κB p65 distribution from data in (<bold>A</bold>). The x-axis shows the enrichment of p65 in the cytoplasm relative to the nucleus. Data are means + SD (n = 3), &gt;100 cells were analyzed per condition. **p≤0.01, ***p≤0.001 from two-sided t-test. (<bold>C</bold>) Expression of poly-GA does not alter the degradation of IκB and phosphorylation of p65. HEK293 cells were transfected with the indicated constructs (Ct: Control; NES: NES-GA<sub>65</sub>-GFP; NLS: NLS-GA<sub>65</sub>-GFP; NT: GA<sub>65</sub>-GFP; PY: GA<sub>65</sub>-GFP-PY) and treated as described in (<bold>A</bold>). Levels of IκB and phosphorylated NF-κB p65 (P–p65) were analyzed by immunoblotting. α-tubulin served as loading control.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig4">Figure 4B</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig4-data1-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Importins form aggregates in cells containing cytoplasmic poly-GA aggregates and are partially sequestered.</title><p>HEK293 cells were left untreated (Control) or were transfected with GA<sub>65</sub>-GFP, NES-GA<sub>65</sub>-GFP or NLS-GA<sub>65</sub>-GFP (green). Cells were then analyzed by immunofluorescence with antibodies against importin α-1 (KPNA2; <bold>A</bold>), importin α-3 (KPNA4; <bold>B</bold>), and importin β-1 (KPNB1; <bold>C</bold>) (red). Close-up views of inclusions are shown, and arrowheads indicate importin aggregates and/or their sequestration at the periphery of the inclusion. The co-localization profile along the white arrow is shown, plotted as percentage of maximal fluorescence on the y-axis. The white dashed lines delineate nuclei based on DAPI staining. Scale bars are 10 µm.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig4-figsupp1-v1.tif"/></fig></fig-group><p>Cytoplasmic aggregates of β-sheet model proteins and disease-linked, amyloidogenic proteins cause mislocalization and sequestration of nuclear pore complexes and importins (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Particularly, R-DPRs have also been shown to directly bind and interfere with cargo loading onto importin β at the nuclear pore (<xref ref-type="bibr" rid="bib32">Hayes et al., 2020</xref>). While cytoplasmic poly-GA aggregates had no apparent effect on the localization of the nuclear pore complex (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), we found that cells with cytoplasmic GA<sub>65</sub>-GFP aggregates frequently contained aggregate foci of importins α1 (KPNA2) and α3 (KPNA4), as has been observed previously for cytoplasmic aggregates of the aggregation-prone model proteins NES-β23 (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). This effect was also observed for importin β1 (KPNB1), although to a lesser degree (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Additionally, importins appeared to be enriched at the periphery of poly-GA inclusions, as seen for KPNA2 and KPNA4 (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Nuclear poly-GA aggregates had no effect on the distribution of these importins (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). Thus, similar to the artificial β-sheet proteins, poly-GA aggregates induce compartment-specific cellular defects and impair nucleocytoplasmic protein transport.</p></sec><sec id="s2-3"><title>G<sub>4</sub>C<sub>2</sub> repeat mRNA causes nuclear mRNA retention and pronounced toxicity</title><p>An aberrant distribution of mRNA has been observed in mouse motor neuron-like cells expressing expanded G<sub>4</sub>C<sub>2</sub> repeats and in <italic>C9orf72</italic> patient cortical neurons (<xref ref-type="bibr" rid="bib22">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Rossi et al., 2015</xref>). We used an oligo-dT probe to test whether cytoplasmic poly-GA aggregates, generated from constructs lacking G<sub>4</sub>C<sub>2</sub>, affect the cellular distribution of total mRNA. In control cells, mRNA was present throughout the cytoplasm and in small nuclear ribonucleic particles (<xref ref-type="fig" rid="fig5">Figure 5A</xref>; <xref ref-type="bibr" rid="bib12">Carter et al., 1991</xref>). Expression of NES-GA<sub>65</sub>-GFP had only a minor effect on cellular mRNA distribution (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>), in contrast to the expression of cytoplasmic β-protein (NES-β17), which resulted in pronounced nuclear mRNA retention (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). Likewise, NLS-GA<sub>65</sub>-GFP only caused limited mRNA retention in the nucleus (<xref ref-type="fig" rid="fig5">Figure 5A, B</xref>). Thus, poly-GA aggregates interfere with the function of only a subset of nuclear transport factors.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Protein biosynthesis defects correlate with retention of mRNA in the nucleus induced by G<sub>4</sub>C<sub>2</sub> mRNA as well as presence of nuclear poly-GA aggregates.</title><p>(<bold>A</bold>) G<sub>4</sub>C<sub>2</sub>-containing constructs induce strong nuclear mRNA accumulation. HEK293 cells were transfected with the indicated constructs: empty vector (Control); NES-GA<sub>65</sub>-GFP (NES-GA); NES-G<sub>4</sub>C<sub>2</sub>-GFP (NES-G<sub>4</sub>C<sub>2</sub>); NES-β17; NLS-GA<sub>65</sub>-GFP (NLS-GA); NLS-G<sub>4</sub>C<sub>2</sub>-GFP (NLS-G<sub>4</sub>C<sub>2</sub>); NLS-β17. PolyA-RNA was detected by fluorescence in situ hybridization using a poly-dT probe (red); protein aggregates (Agg) green. (<bold>B</bold>) Quantification of data in (<bold>A</bold>). The graph shows the fraction of cells with nuclear mRNA accumulation. Data are means + SD (n = 3), ***p≤0.001 from two-sided t-test. (<bold>C</bold>) G<sub>4</sub>C<sub>2</sub>-containing constructs induce the formation of G<sub>4</sub>C<sub>2</sub> RNA foci. HEK293 cells were transfected with the indicated constructs: empty vector (Control); NES-GA<sub>65</sub>-GFP (NES-GA); NES-G<sub>4</sub>C<sub>2</sub>-GFP (NES-G<sub>4</sub>C<sub>2</sub>); NLS-GA<sub>65</sub>-GFP (NLS-GA); NLS-G<sub>4</sub>C<sub>2</sub>-GFP (NLS-G<sub>4</sub>C<sub>2</sub>). Cells were analyzed for GFP fluorescence (green) and C<sub>4</sub>G<sub>2</sub> fluorescence by in situ hybridization (red). (<bold>D</bold>) Decreased protein biosynthesis in the presence of nuclear poly-GA and G<sub>4</sub>C<sub>2</sub> mRNA. Newly synthesized proteins were labeled with O-propargyl-puromycin (OPP; red) in HEK293 cells transfected with the indicated constructs (green). The white dashed lines delineate the nucleus based on DAPI staining, and the scale bar represents 10 µm. (<bold>E</bold>) Quantification of data in (<bold>D</bold>). Analysis of control cells transfected with empty vector and treated with the translation inhibitor cycloheximide (CHX) when indicated is included as control. Boxplot of a representative experiment is shown. Center lines show the medians; box limits indicate the 25th and 75th percentiles; whiskers extend to the 10th and 90th percentiles, outliers are plotted as circles. Welch's t-test was used to assess statistical significance (**p≤0.01; ***p≤0.001).</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig5">Figure 5B</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig5-data1-v1.docx"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Numerical values for repeats for <xref ref-type="fig" rid="fig5">Figure 5E</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig5-data2-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Expression of G<sub>4</sub>C<sub>2</sub>-containing constructs induces mRNA retention in the nucleus.</title><p>(<bold>A</bold>) Presence of G<sub>4</sub>C<sub>2</sub> rather than aggregate localization causes nuclear mRNA retention. HEK293 cells were transfected with either GA<sub>65</sub>-GFP (GA) or G<sub>4</sub>C<sub>2</sub>-GFP (G<sub>4</sub>C<sub>2</sub>) and analyzed for nuclear mRNA accumulation as in <xref ref-type="fig" rid="fig5">Figure 5A, B</xref>. Cells containing GA-GFP aggregates in the cytoplasm (Cyt) or nucleus (Nuc) were analyzed separately. Data are shown as means + SD (n = 3). (<bold>B</bold>) mRNA retention correlates with the presence of G<sub>4</sub>C<sub>2</sub> positive nuclear foci. HEK293 cells were transfected with G<sub>4</sub>C<sub>2</sub>-GFP (G<sub>4</sub>C<sub>2</sub>), NES-G<sub>4</sub>C<sub>2</sub>-GFP (NES-G<sub>4</sub>C<sub>2</sub>), or NLS-G<sub>4</sub>C<sub>2</sub>-GFP (NLS-G<sub>4</sub>C<sub>2</sub>) and analyzed for mRNA nuclear accumulation as in <xref ref-type="fig" rid="fig5">Figure 5C</xref>. Fluorescence in situ hybridization was performed as in <xref ref-type="fig" rid="fig5">Figure 5C</xref> to detect G<sub>4</sub>C<sub>2</sub> foci. Cells were categorized according to the presence of G<sub>4</sub>C<sub>2</sub>-positive foci as well as aggregates. Data are shown as means + SD (n = 3).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig5-figsupp1-v1.tif"/></fig></fig-group><p>Given that expression of poly-GA protein alone did not recapitulate the alterations of mRNA localization observed in <italic>C9orf72</italic> patient brain (<xref ref-type="bibr" rid="bib22">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib66">Rossi et al., 2015</xref>), we next analyzed the effect of an ATG-driven poly-GA construct of 73 GA repeats encoded entirely by G<sub>4</sub>C<sub>2</sub> motifs (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub> (<xref ref-type="fig" rid="fig1">Figure 1A,</xref> <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Comparable to the synthetic GA<sub>65</sub>-GFP sequences, these constructs also generated poly-GA protein aggregates in the cytoplasm or nucleus (<xref ref-type="fig" rid="fig5">Figure 5A, C</xref>). Importantly, as cytoplasmic poly-GA did not induce toxicity in our cell system, the use of NES and NLS targeting sequences allowed us to isolate the contribution of the G<sub>4</sub>C<sub>2</sub>-containing RNA to cellular pathology. Both NES-(G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP and NLS-(G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP, besides generating DPR inclusions, resulted in the formation of G<sub>4</sub>C<sub>2</sub>-positive RNA foci in the nucleus, as observed by fluorescent in situ hybridization (FISH) using a C<sub>4</sub>G<sub>2</sub> probe (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Cells expressing GA<sub>65</sub>-GFP or (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP without targeting sequence were analyzed as well, but only the G<sub>4</sub>C<sub>2</sub> constructs showed mRNA accumulation in the nucleus of the majority of cells (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>). Furthermore, simultaneous visualization of G<sub>4</sub>C<sub>2</sub> RNA puncta with the C<sub>4</sub>G<sub>2</sub> probe, total mRNA using an oligo-dT probe and GA-GFP revealed that the G<sub>4</sub>C<sub>2</sub> RNA foci are associated with nuclear mRNA accumulation, independent of the presence of visible poly-GA protein aggregates (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>). Together, these results indicate that G<sub>4</sub>C<sub>2</sub> RNA, not poly-GA protein, mediates retention of mRNA in the nucleus.</p><p>The nuclear mRNA retention in cells expressing G<sub>4</sub>C<sub>2</sub> constructs was accompanied by a marked reduction of protein synthesis as measured by the incorporation of a puromycin derivative into newly translated proteins (<xref ref-type="bibr" rid="bib75">Slomnicki et al., 2016</xref>; <xref ref-type="fig" rid="fig5">Figure 5D, E</xref>). Interestingly, NLS-GA<sub>65</sub>-GFP-expressing cells also displayed reduced protein synthesis, independently of G<sub>4</sub>C<sub>2</sub> RNA. In contrast, NES-GA<sub>65</sub>-GFP had no inhibitory effect on protein synthesis (<xref ref-type="fig" rid="fig5">Figure 5D, E</xref>). Notably, cells expressing NLS-(G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP, accumulating both nuclear poly-GA protein and G<sub>4</sub>C<sub>2</sub> RNA, were almost completely translation inactive, similar to control cells treated with the translation inhibitor cycloheximide (<xref ref-type="fig" rid="fig5">Figure 5D, E</xref>). Thus, both nuclear poly-GA protein and G<sub>4</sub>C<sub>2</sub> RNA appear to have additive inhibitory effects on protein biosynthesis. We next measured the proliferation rate or viability of cells transiently transfected with either synthetic or G<sub>4</sub>C<sub>2</sub>-containing constructs. Independent of the presence of a NES or NLS targeting sequence, all G<sub>4</sub>C<sub>2</sub> constructs markedly decreased cellular viability (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), indicating that toxicity was mediated by the expanded G<sub>4</sub>C<sub>2</sub> RNA. Moreover, expression of NLS-(G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP was more toxic than NLS-GA<sub>65</sub>-GFP (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), although the poly-GA levels of the constructs were comparable (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>).</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Production of G<sub>4</sub>C<sub>2</sub> mRNA strongly decreases cellular viability.</title><p>(<bold>A</bold>) G<sub>4</sub>C<sub>2</sub> mRNA induces strong toxicity. HEK293 cells were transfected with the indicated constructs: G<sub>4</sub>C<sub>2</sub>-GFP (G<sub>4</sub>C<sub>2</sub>), NES-G<sub>4</sub>C<sub>2</sub>-GFP (NES-G<sub>4</sub>C<sub>2</sub>), NLS-G<sub>4</sub>C<sub>2</sub>-GFP (NLS-G<sub>4</sub>C<sub>2</sub>), GA<sub>65</sub>-GFP (GA), NES-GA<sub>65</sub>-GFP (NES-GA), NLS-GA<sub>65</sub>-GFP (NLS-GA), PR<sub>73</sub>-GFP (PR), or GR<sub>73</sub>-GFP (GR). MTT cell viability assays were performed 4 days after transfection. Data were normalized to cells transfected with empty vector. Data are means + SD (n ≥ 3). Part of this data is also shown in <xref ref-type="fig" rid="fig2">Figure 2D</xref>. *p≤0.05; ***p≤0.001 from two-sided t-test. (<bold>B</bold>) (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP does not produce detectable amounts of arginine containing dipeptide repeats (R-DPRs). HEK293 cells were transfected with the indicated constructs: empty vector (control), (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP (G<sub>4</sub>C<sub>2</sub>), PR<sub>73</sub>-GFP (PR), and GR<sub>73</sub>-GFP (GR). Immunoblot analysis was then performed against GFP (left), poly-PR (center), and poly-GR (right). A representative result of three biological repeats is shown. The arrows indicate the main band of the respective DPRs, and * indicate non-specific bands recognized by the anti-GR antibody.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Numerical values for graph in <xref ref-type="fig" rid="fig6">Figure 6A</xref>.</title></caption><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-fig6-data1-v1.docx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Expression levels of GA-DPRs and localization of R-DPRs.</title><p>(<bold>A</bold>) Toxicity induced by G<sub>4</sub>C<sub>2</sub> mRNA is not due to a higher poly-GA level. HEK293 cells were transfected with the indicated constructs: NES-GA<sub>65</sub>-GFP (NES-GA); NES-G<sub>4</sub>C<sub>2</sub>-GFP (NES-G<sub>4</sub>C<sub>2</sub>); NLS-GA<sub>65</sub>-GFP (NLS-GA); and NLS-G<sub>4</sub>C<sub>2</sub>-GFP (NLS-G<sub>4</sub>C<sub>2</sub>). Poly-GA-GFP protein levels were analyzed by immunoblotting against GFP. α-tubulin served as loading control. A representative result of three independent experiments is shown. (<bold>B</bold>) Arginine-containing dipeptide repeats (R-DPRs) accumulate in the nucleolus. HEK293 cells were transfected with the indicated constructs (GR<sub>73</sub>-GFP (GR); PR<sub>73</sub>-GFP (PR)). Cells were then stained with anti-nucleophosmin (NPM1, red). Expressed constructs are shown in green. The white dashed lines delineate the nucleus based on DAPI staining, and the scale bar represents 10 µm. </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-62718-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Long sequences of repeated G<sub>4</sub>C<sub>2</sub> motifs can produce a series of different DPRs by RAN translation (<xref ref-type="bibr" rid="bib4">Ash et al., 2013</xref>; <xref ref-type="bibr" rid="bib26">Gendron et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Mori et al., 2013a</xref>; <xref ref-type="bibr" rid="bib54">Mori et al., 2013c</xref>; <xref ref-type="bibr" rid="bib103">Zu et al., 2013</xref>). Since the R-DPRs (poly-PR and poly-GR) have been reported to be toxic in cellular models (<xref ref-type="bibr" rid="bib7">Boeynaems et al., 2016</xref>; <xref ref-type="bibr" rid="bib22">Freibaum et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>; <xref ref-type="bibr" rid="bib81">Tao et al., 2015</xref>; <xref ref-type="bibr" rid="bib103">Zu et al., 2013</xref>), we investigated whether the G<sub>4</sub>C<sub>2</sub> constructs produced R-DPRs at levels sufficient to explain the observed toxicity independently of G<sub>4</sub>C<sub>2</sub> RNA effects. To this end, we engineered synthetic sequences, resulting in the ATG-driven synthesis of 73 GR or 73 PR repeats (GR<sub>73</sub>-GFP and PR<sub>73</sub>-GFP, respectively) without G<sub>4</sub>C<sub>2</sub> repeats. GR<sub>73</sub>-GFP was located predominantly within the cytoplasm and the nucleolus of HEK293 cells, while PR<sub>73</sub>-GFP accumulated within the nucleoplasm and nucleolus (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B</xref>), as reported previously (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib49">May et al., 2014</xref>; <xref ref-type="bibr" rid="bib91">White et al., 2019</xref>). While the expression of (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP dramatically reduced cellular viability, the R-DPRs were not measurably cytotoxic (<xref ref-type="fig" rid="fig6">Figure 6A</xref>), consistent with an earlier report for constructs with longer repeat lengths (<xref ref-type="bibr" rid="bib49">May et al., 2014</xref>). We used specific anti-GR and anti-PR antibodies to determine the relative accumulation of the R-DPRs in (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP-expressing cells in comparison to cells expressing GR<sub>73</sub>-GFP and PR<sub>73</sub>-GFP. The antibodies recognized specific signals in cells transfected with the respective R-DPR constructs, but failed to detect R-DPR protein in cells expressing (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP (<xref ref-type="fig" rid="fig6">Figure 6B</xref>), indicating that production of R-DPR protein from the G<sub>4</sub>C<sub>2</sub> constructs was very inefficient. Given that PR<sub>73</sub>-GFP and GR<sub>73</sub>-GFP were produced in detectable quantities from the synthetic constructs without inducing toxicity, we conclude that the pronounced toxicity observed upon expression of (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub>-GFP cannot be explained by RAN translation of R-DPR but is due to nuclear mRNA retention mediated by the G<sub>4</sub>C<sub>2</sub> repeat RNA.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We have employed a cellular model to differentiate possible mechanisms of toxicity exerted by expansion of the G<sub>4</sub>C<sub>2</sub> hexanucleotide tract within the <italic>C9orf72</italic> locus, the most frequent genetic cause of ALS and FTD (<xref ref-type="bibr" rid="bib18">DeJesus-Hernandez et al., 2011</xref>; <xref ref-type="bibr" rid="bib63">Renton et al., 2011</xref>). Our results demonstrated that the G<sub>4</sub>C<sub>2</sub> expansion causes toxicity in our cellular system in a manner dependent on both aggregates of G<sub>4</sub>C<sub>2</sub>-encoded DPR proteins and the G<sub>4</sub>C<sub>2</sub> repeat mRNA. These findings suggest a multiple hit model of additive, but mechanistically independent, effects of proteotoxicity and RNA-mediated toxicity, with the latter being the predominant toxic agent in the model system investigated. However, the longer G<sub>4</sub>C<sub>2</sub> expansions, and the resulting DPRs, present in patients may have additional adverse effects that were not recapitulated with the constructs used here.</p><p>Both DPRs and repeat mRNA interfered with different aspects of nucleocytoplasmic transport. The G<sub>4</sub>C<sub>2</sub> RNA inhibited the export of mRNA from the nucleus, consistent with a dramatic impairment of protein synthesis that would be associated with strong neuronal toxicity. Notably, this effect was independent of the presence of DPR protein aggregates, which is in agreement with results from zebrafish (<xref ref-type="bibr" rid="bib80">Swinnen et al., 2018</xref>), but in contrast to findings observed in <italic>Drosophila</italic> (<xref ref-type="bibr" rid="bib82">Tran et al., 2015</xref>). Additionally, as has been reported for artificial β-sheet proteins and disease-associated aggregation-prone proteins such as Tau, Huntingtin, FUS, and TDP-43 (<xref ref-type="bibr" rid="bib13">Chou et al., 2018</xref>; <xref ref-type="bibr" rid="bib20">Dormann et al., 2010</xref>; <xref ref-type="bibr" rid="bib21">Eftekharzadeh et al., 2019</xref>; <xref ref-type="bibr" rid="bib25">Gasset-Rosa et al., 2017</xref>; <xref ref-type="bibr" rid="bib29">Grima et al., 2017</xref>; <xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>), cytoplasmic poly-GA aggregates partially inhibited the transport of proteins across the nuclear pore. This observation is in agreement with the previously reported sequestration of a subset of transport factors by poly-GA (<xref ref-type="bibr" rid="bib38">Khosravi et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Solomon et al., 2018</xref>; <xref ref-type="bibr" rid="bib99">Zhang et al., 2016</xref>), and the importin pathology that has been observed in postmortem frontal cortex tissue of ALS/FTD <italic>C9orf72</italic> patients (<xref ref-type="bibr" rid="bib76">Solomon et al., 2018</xref>). Interestingly, other DPRs have also been reported to inhibit additional aspects of nucleocytoplasmic transport (<xref ref-type="bibr" rid="bib8">Boeynaems et al., 2017</xref>; <xref ref-type="bibr" rid="bib14">Cook et al., 2020</xref>; <xref ref-type="bibr" rid="bib44">Lee et al., 2016</xref>; <xref ref-type="bibr" rid="bib46">Lin et al., 2016</xref>; <xref ref-type="bibr" rid="bib100">Zhang et al., 2018a</xref>). Poly-PR can directly obstruct the central channel of the nuclear pore by binding to the FG domains of nuclear pore proteins (<xref ref-type="bibr" rid="bib72">Shi et al., 2017</xref>), and R-DPRs can disrupt cargo loading onto karyopherins β (<xref ref-type="bibr" rid="bib32">Hayes et al., 2020</xref>).</p><p>While the effects of cytoplasmic poly-GA (NES-poly-GA) aggregates on nuclear transport were well tolerated in our cell culture model, poly-GA aggregates within the nucleus (NLS-poly-GA) were associated with substantial proteotoxicity. Nuclear poly-GA formed aggregates at sites that were distinct from nucleoli, similar to the localization of poly-GA aggregates observed in patient brain (<xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>). However, formation of these inclusions altered the shape of nucleoli as a result of mislocalization and partial sequestration of the abundant GC protein NPM1, consistent with the nucleolar abnormalities reported in neurons from C9orf72 cases (<xref ref-type="bibr" rid="bib50">Mizielinska et al., 2017</xref>). Nuclear poly-GA aggregates interfered with the recently described protein quality control function of the GC phase of the nucleolus (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>), as demonstrated using the metastable firefly luciferase as a model substrate. In cells containing nuclear poly-GA aggregates, misfolded luciferase failed to repartition from the nucleolus to the nucleoplasm during recovery from stress. This inhibitory effect was comparable to that previously observed for positively charged DPRs, such as poly-PR, which accumulate directly within the GC phase of the nucleolus (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib50">Mizielinska et al., 2017</xref>; <xref ref-type="bibr" rid="bib81">Tao et al., 2015</xref>). However, R-DPRs apparently do not accumulate in the nucleolus in patient brain (<xref ref-type="bibr" rid="bib48">Mackenzie et al., 2015</xref>; <xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>), and thus may rather interfere with nucleolar quality control by the mechanism described here for nuclear poly-GA (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>; <xref ref-type="bibr" rid="bib42">Kwon et al., 2014</xref>; <xref ref-type="bibr" rid="bib91">White et al., 2019</xref>).</p><p>Expression of poly-GA from G<sub>4</sub>C<sub>2</sub>-containing constructs resulted in substantially greater toxicity than expression from synthetic constructs when similar poly-GA lengths and amounts were compared. The G<sub>4</sub>C<sub>2</sub> hexanucleotide repeat is thought to exert toxic effects in part by forming higher-order RNA assemblies in the nucleus that sequester RNA-binding proteins (<xref ref-type="bibr" rid="bib2">Almeida et al., 2013</xref>; <xref ref-type="bibr" rid="bib16">Cooper-Knock et al., 2015</xref>; <xref ref-type="bibr" rid="bib15">Cooper-Knock et al., 2014</xref>; <xref ref-type="bibr" rid="bib19">Donnelly et al., 2013</xref>; <xref ref-type="bibr" rid="bib31">Haeusler et al., 2014</xref>; <xref ref-type="bibr" rid="bib53">Mori et al., 2013b</xref>; <xref ref-type="bibr" rid="bib62">Reddy et al., 2013</xref>; <xref ref-type="bibr" rid="bib66">Rossi et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Sareen et al., 2013</xref>; <xref ref-type="bibr" rid="bib94">Xu et al., 2013</xref>). Even if longer G<sub>4</sub>C<sub>2</sub> sequences may mediate additional effects (<xref ref-type="bibr" rid="bib90">West et al., 2020</xref>), the G<sub>4</sub>C<sub>2</sub> constructs tested here resulted in a pronounced inhibition of protein synthesis, even when coding for cytoplasmic poly-GA protein (NES-GA<sub>65</sub>), which did not impair protein biogenesis when produced from a synthetic (non-G<sub>4</sub>C<sub>2)</sub> construct. However, because expression constructs based on G<sub>4</sub>C<sub>2</sub> repeats also generate the different RAN translation DPR products, a clear distinction between RNA and DPR toxicity in previous studies had been difficult. We therefore compared not only the relative toxicity of poly-GA and G<sub>4</sub>C<sub>2</sub> constructs, but also measured the toxicity of poly-PR and poly-GR constructs in the absence of G<sub>4</sub>C<sub>2</sub> repeat RNA. Notably, expression of these protein-only constructs did not induce overt toxicity even when expressed at levels much higher than those generated by RAN translation of the G<sub>4</sub>C<sub>2</sub> repeat. These findings allowed us to unequivocally attribute the major component of toxicity associated with G<sub>4</sub>C<sub>2</sub> constructs to the production of the pathological G<sub>4</sub>C<sub>2</sub> RNA sequence. Although DPRs may be undetectable in the brain regions most affected by neurodegeneration in <italic>C9orf72</italic> patients (<xref ref-type="bibr" rid="bib69">Schludi et al., 2015</xref>), we cannot exclude a DPR contribution to pathology in carriers of G<sub>4</sub>C<sub>2</sub> expansions, where combinations of the various DPRs and mRNA are present simultaneously, and nondividing cells are exposed to these factors for extended time periods. Indeed, nuclear poly-GA also interfered with protein biosynthesis, presumably by impairing the nucleolar function in ribosome biogenesis, and thus could enhance the toxic effects of G<sub>4</sub>C<sub>2</sub> repeat RNA.</p><p>In summary, our results indicate that the G<sub>4</sub>C<sub>2</sub> expansion in <italic>C9orf72</italic> interferes with multiple nuclear functions, culminating in an inhibition of protein biogenesis, an outcome that would be especially harmful to neuronal cells. These dominant toxic effects might be further aggravated by a loss of function of the endogenous C9ORF72 protein, which is thought to play a role in cellular quality control (<xref ref-type="bibr" rid="bib9">Boivin et al., 2020</xref>; <xref ref-type="bibr" rid="bib70">Sellier et al., 2016</xref>; <xref ref-type="bibr" rid="bib78">Sullivan et al., 2016</xref>; <xref ref-type="bibr" rid="bib96">Yang et al., 2016</xref>; <xref ref-type="bibr" rid="bib102">Zhu et al., 2020</xref>). Further research on the relative contribution of the different toxic mechanisms will be important in developing therapeutic strategies.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Cell line (<italic>Homo sapiens</italic>, female)</td><td valign="top">HEK293</td><td valign="top">ATCC</td><td valign="top">Cat. #: ATCC-CRL-1573 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/CVCL_0045">CVCL_0045</ext-link></td><td valign="top">Lot/Batch No: 63777489</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 GA<sub>65</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 NES-GA<sub>65</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 NLS-GA<sub>65</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 NLS-GA<sub>65</sub>-GFP (K7T, K15T)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 GA<sub>65</sub>-GFP-PY</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 GA<sub>65</sub>-GFP-PY(P410L)</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 1 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 PR<sub>73</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 3 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 GR<sub>73</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 3 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 (G4C2)<sub>73</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 3 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 NLS-(G4C2)<sub>73</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 3 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">pcDNA3.1 NES-(G4C2)<sub>73</sub>-GFP</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 3 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid expressing <break/>NLS-LS</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/31296649/">31296649</ext-link></td><td valign="top"/><td valign="top">Prof. F. Ulrich Hartl (Max Planck Institute for Biochemistry)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid expressing <break/>S-mApple</td><td valign="top">This paper</td><td valign="top"/><td valign="top">Described in Results part 2 and Materials and methods section</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid expressing c-myc-NES-β17</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26634439/">26634439</ext-link></td><td valign="top"/><td valign="top">Prof. F. Ulrich Hartl (Max Planck Institute for Biochemistry)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid expressing c-myc-NLS-β17</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26634439/">26634439</ext-link></td><td valign="top"/><td valign="top">Prof. F. Ulrich Hartl (Max Planck Institute for Biochemistry)</td></tr><tr><td valign="top">Recombinant DNA reagent</td><td valign="top">Plasmid expressing <break/>Htt96Q</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26634439/">26634439</ext-link></td><td valign="top"/><td valign="top">Prof. F. Ulrich Hartl (Max Planck Institute for Biochemistry)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-nuclear pore complex proteins</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab24609 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_448181">AB_448181</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-NPM1</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: 32-5200 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2533084">AB_2533084</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-NF-κB p65 (D14E12)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 8242 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10859369">AB_10859369</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-p62</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab203430 RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2728795">AB_2728795</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-c-Myc-Cy3 (9E10)</td><td valign="top">Sigma</td><td valign="top">Cat. #: C6594 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_258958">AB_258958</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-amyloid fibrils OC</td><td valign="top">Millipore</td><td valign="top">Cat. #: AB2286 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1977024">AB_1977024</ext-link></td><td valign="top">IF (1:500)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse biclonal anti-GFP</td><td valign="top">Roche</td><td valign="top">Cat. #: 11814460001 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_390913">AB_390913</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-α-tubulin</td><td valign="top">Sigma</td><td valign="top">Cat. #: T6199 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_477583">AB_477583</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-RPA40</td><td valign="top">Santa Cruz</td><td valign="top">Cat. #: sc-374443 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10991310">AB_10991310</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-IκBα (L35A5)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 4814 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_390781">AB_390781</ext-link></td><td valign="top">WB (1:/1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit monoclonal anti-phospho-NF-κB p65 (Ser533) (93H1)</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 3033 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_331284">AB_331284</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-KPNA2</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab70160 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2133673">AB_2133673</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-KPNA4</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab84735 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1860702">AB_1860702</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-KPNB1</td><td valign="top">Abcam</td><td valign="top">Cat. #: ab2811 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2133989">AB_2133989</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal <break/>anti-GAPDH</td><td valign="top">Millipore</td><td valign="top">Cat. #: MAB374 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2107445">AB_2107445</ext-link></td><td valign="top">WB (1:2000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Rabbit polyclonal anti-poly-PR</td><td valign="top">Proteintech</td><td valign="top">Cat. #: 23979-1-AP <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2879388">AB_2879388</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Mouse monoclonal anti-poly-GR (5A2)</td><td valign="top">Millipore</td><td valign="top">Cat. #: MABN778 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2728664">AB_2728664</ext-link></td><td valign="top">WB (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat Secondary anti-mouse IgG-Alexa 488</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 4408 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10694704">AB_10694704</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat Secondary anti-mouse IgG-Alexa 555</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 4409 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_1904022">AB_1904022</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Goat Secondary anti-rabbit IgG-Alexa 555</td><td valign="top">Cell Signaling Technology</td><td valign="top">Cat. #: 4413 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_10694110">AB_10694110</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Secondary chicken anti-mouse IgG-Alexa 488</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: 21200 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535786">AB_2535786</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Secondary goat anti-mouse IgG-Alexa 633</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: A21053 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535720">AB_2535720</ext-link></td><td valign="top">IF (1:1000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Secondary goat anti-mouse IgG-peroxidase</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: A4416 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_258167">AB_258167</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Antibody</td><td valign="top">Secondary goat anti-rabbit IgG-peroxidase</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: A9169 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_258434">AB_258434</ext-link></td><td valign="top">WB (1:10,000)</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">T<sub>30</sub></td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/26634439/">26634439</ext-link></td><td valign="top">FISH probe</td><td valign="top">Cy5-conjugated</td></tr><tr><td valign="top">Sequence-based reagent</td><td valign="top">(C<sub>4</sub>G<sub>2</sub>)<sub>5</sub></td><td valign="top">This paper</td><td valign="top">FISH probe</td><td valign="top">Cy3-conjugated</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">UltraPure SSC buffer</td><td valign="top">Thermo Fisher Scientific</td><td valign="top">Cat. #: 15557044</td><td valign="top">For FISH</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Formamide</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: 47671</td><td valign="top">For FISH</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Dextran sulphate</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: D6001</td><td valign="top">For FISH</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">AmyTracker 680 (AmyT)</td><td valign="top">Ebba Biotech AB</td><td valign="top">Cat. #: AmyTracker 680</td><td valign="top">Amyloid dye</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">DAPI</td><td valign="top">Invitrogen</td><td valign="top">Cat. #: D1306 <break/>RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2629482">AB_2629482</ext-link></td><td valign="top">Nuclear stain</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Thiazolyl blue tetrazolium bromide</td><td valign="top">Sigma Aldrich</td><td valign="top">Cat. #: M2128</td><td valign="top">For cell viability</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">N,N-dimethylformamide</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: D4551</td><td valign="top">For cell viability</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">SDS</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: L3771</td><td valign="top">For cell viability</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Acetic acid</td><td valign="top">Sigma-Aldrich</td><td valign="top">Cat. #: A6283</td><td valign="top">For cell viability</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Leptomycin B</td><td valign="top">Sigma Aldrich</td><td valign="top">Cat. #: L2913</td><td valign="top">See Materials and methods section</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">CellTiter-Glo 2.0</td><td valign="top">Promega</td><td valign="top">Cat. #: G9241</td><td valign="top">For cell viability</td></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Lipofectamine 2000 transfection reagent</td><td valign="top">Thermo Fischer Scientific</td><td valign="top">Cat. #: 11668019</td><td valign="top"/></tr><tr><td valign="top">Commercial assay or kit</td><td valign="top">Click-iT Plus OPP Alexa Fluor 594 Protein Synthesis Assay Kit</td><td valign="top">Thermo Fischer Scientific</td><td valign="top">Cat. #: C10457</td><td valign="top"/></tr><tr><td valign="top">Peptide, recombinant protein</td><td valign="top">Human recombinant TNFα</td><td valign="top">Jena Biosciences</td><td valign="top">Cat. #: PR-430</td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Cell culture, transfection, and cell treatments</title><p>Human embryonic kidney cells (ATCC-CRL-1573) were obtained from ATCC and maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Biochrom KG) supplemented with 10% fetal bovine serum (Gibco), 100 U/ml penicillin and 100 μg/ml streptomycin sulfate (Gibco), 2 mM L-glutamine (Gibco), and 5 μg/ml Plasmocin (InvivoGen). Cells were authenticated by DNA fingerprint STR analysis by the supplier and were visually inspected using DAPI DNA staining and tested negative for mycoplasma contamination. For heat stress (HS) and recovery experiments, cells were either maintained at 37°C (-HS), or placed in a 43°C (+HS) incubator for the indicated duration, or subjected to heat stress and then transferred back to 37°C for recovery (+HS + Rec). Transient transfections were performed by electroporation with the GenePulser XCell System (Bio-Rad) or with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s instructions. For assessing nuclear import of p65, transfected cells were treated with 20 ng/ml recombinant human TNFα (Jena Biosciences) for 30 min. For translation inhibition, cycloheximide (CHX, Sigma-Aldrich) was dissolved in phosphate buffered saline (PBS) and applied at a final concentration of 1 mM.</p></sec><sec id="s4-2"><title>Plasmids</title><p>Degenerated sequences encoding 65 GA<sup>ggxgcx</sup> repeats preceded by a start codon (ATG) and flanked by NheI and BamHI restriction sites were chemically synthesized by GeneArt Gene Synthesis (Invitrogen). The GC content of sequence 1 is 77.2%, while sequence 2 contains 81.5% GC (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). Both GA<sub>65</sub> sequences were cloned into pcDNA3.1-myc/His A plasmids in frame with GFP at the C-terminus. An N-terminal nuclear export signal (NES) or an N-terminal double SV40 nuclear localization signal (NLS) was inserted by site-directed mutagenesis. The alternative FUS-derived nuclear localization signal (PY) was inserted C-terminally. Point mutations were introduced by site-directed mutagenesis. Similarly, degenerated sequences encoding PR<sub>73</sub> and GR<sub>73</sub> were generated by GeneArt Gene Synthesis (Invitrogen) and fused to the N-terminus of GFP. All sequences contained an ATG start codon. Sequences encoding (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub> repeats preceded by a start codon (ATG) were generated as previously described by primer hybridization (<xref ref-type="bibr" rid="bib30">Guo et al., 2018</xref>). Similarly, the (G<sub>4</sub>C<sub>2</sub>)<sub>73</sub> construct was subcloned in place of the degenerated GA<sub>65</sub> sequence in the same NES/NLS-tagged GFP-containing vector. A GFP-only construct was generated by deletion of the GA from the same vector. NLS-LS has been previously described (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>). The plasmid encoding for S-mApple was generated from mApple-N1 (Addgene plasmid # 54567), a kind gift from Michael Davidson (<xref ref-type="bibr" rid="bib71">Shaner et al., 2008</xref>). mApple was then cloned between BamHI and XbaI to replace GFP in a previously described plasmid encoding shuttle GFP (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). c-myc-NES-β17, c-myc-NLS-β17, and Htt96Q plasmids have been previously described (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). All relevant plasmid regions were verified by sequencing.</p></sec><sec id="s4-3"><title>Antibodies and dyes</title><p>The following primary antibodies were used in this study: nuclear pore complex proteins (Mab414), Abcam (24609); NPM1, Invitrogen (32-5200); NF-κB p65 (D14E12), Cell Signaling Technology (#8242); c-Myc-Cy3 (9E10), Sigma (C6594); amyloid fibrils, OC, Millipore (AB2286); GFP, Roche (11814460001); α-tubulin, Sigma Aldrich (T6199); RPA40, Santa Cruz (sc-374443); IκBα (L35A5), Cell Signaling Technology (#4814); phospho-NF-κB p65 (Ser536) (93H1), Cell Signaling Technology (#3033); KPNA2, Abcam (ab70160); KPNA4, Abcam (ab84735); KPNB1, Abcam (ab2811); GAPDH, Millipore (MAB374); poly-PR, Proteintech (23979-1-AP); and poly-GR (5A2), Millipore (MABN778).</p><p>The following secondary antibodies were used: mouse IgG-Alexa488, Cell Signaling Technology (#4408); mouse IgG-Alexa555, Cell Signaling Technology (#4409); rabbit IgG-Alexa555, Cell Signaling Technology (#4413); mouse IgG-Alexa488, Invitrogen (21200); mouse IgG-Alexa 633, Invitrogen (A21053); anti-mouse IgG-Peroxidase, Sigma Aldrich (A4416); and anti-rabbit IgG-Peroxidase, Sigma Aldrich (A9169). The amyloid dye AmyTracker 680 (AmyT; Ebba Biotech AB) was used as previously described (<xref ref-type="bibr" rid="bib23">Frottin et al., 2019</xref>). Briefly, cells were fixed in 4% paraformaldehyde in PBS (Gibco) for 20 min, washed with PBS, and permeabilized with Triton X-100 0.1% for 5 min. AmyT was used at 1:500 dilution and incubated with the samples for 1 hr at room temperature. Nuclei were counterstained with 4',6-diamidine-2'-phenylindole dihydrochloride (DAPI, Molecular Probes).</p></sec><sec id="s4-4"><title>Immunofluorescence and image acquisition</title><p>Cells were grown on poly-L-lysine-coated coverslips (Neuvitro). Cells were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, and blocked with 1% bovine serum albumin in PBS. Primary antibodies were applied in blocking buffer supplemented with 0.1% Triton X-100 and incubated overnight at 4°C. Appropriate fluorescent secondary antibodies at a dilution of 1:500 were applied for 60 min at room temperature. Nuclei were counterstained with DAPI before mounting samples with fluorescence-compatible mounting medium (DAKO).</p><p>Confocal microscopy was performed at MPIB Imaging Facility (Martinsried, Germany) on a ZEISS (Jena, Germany) LSM780 confocal laser scanning microscope equipped with a ZEISS Plan-APO 63×/NA1.46 oil immersion objective. In case of multi-fluorescence samples, a single-stained control sample was used to adjust emission and detection configuration to minimize spectral bleed-through. Images of cells with inclusions for co-localization studies were subjected to linear unmixing with spectra obtained from the single-stained samples using ZEN software. When fluorescence intensities were directly compared, acquisition settings and processing were kept identical. Images were analyzed with ImageJ (Rasband, W.S., National Institutes of Health, USA) and assembled in Adobe Photoshop CC (Adobe Systems Incorporated, Release 19.1.5).</p></sec><sec id="s4-5"><title>Cell viability assay</title><p>HEK293 cells were transfected by electroporation as previously described (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). In brief, cells were electroporated with 20 μg of plasmid in 0.4 cm-gap electroporation cuvettes (Bio-Rad). Cells were electroporated at 225 V, ∞ Ω, 950 μF exponential wave in a GenePulser XCell System (Bio-Rad). After electroporation, cells were plated in a 24-well plate in triplicates. MTT assays were performed 3 days after transfection. The growth medium was replaced with fresh medium containing 5 µg/ml thiazolyl blue tetrazolium bromide (Sigma) for 1 hr. Formazan crystals were solubilized by addition of stop solution, containing 40% N,N-dimethylformamide (Sigma-Aldrich), 16% SDS (Sigma-Aldrich), and 2% (v/v) acetic acid (Sigma-Aldrich). Absorbance at 570 nm and 630 nm was then recorded. Alternatively, viability was measured using the CellTiter-Glo 2.0 Cell Viability Assay kit (Promega) in the same conditions.</p></sec><sec id="s4-6"><title>Determination of nuclear import/export with S-mApple</title><p>Cells were co-transfected with the indicated constructs and the reporter S-mApple. After 48 hr, cells were treated with 10 ng/ml of the CRM1 inhibitor Leptomycin B (LMB, Sigma Aldrich) in DMSO for 15 min before cell fixation. Control cells received DMSO. The relative concentration of S-mApple in the cytoplasm and nucleus was quantified by measuring the fluorescence intensity ratio in cells from three independent experiments. Fluorescence intensities were determined using ImageJ.</p></sec><sec id="s4-7"><title>Protein biosynthesis assay by click-chemistry</title><p>Protein biosynthesis assays were carried out using the click-it plus O-propargyl-puromycin (OPP) protein synthesis assay (Thermo Fisher Scientific) according to the manufacturer’s instructions. Cells were transfected for 24 hr with the indicated construct before metabolic labeling and incubated with the OPP reagent for 30 min in normal growth conditions. As control, protein translation was inhibited with cycloheximide (CHX, Sigma-Aldrich) dissolved in PBS and applied at a final concentration of 1 mM. Samples were then fixed, permeabilized, and the click reaction performed as recommended by the provider. Samples were subsequently analyzed by confocal microscopy. The concentration of labeled proteins was quantified by measuring the mean fluorescence intensity in 100–250 cells using ImageJ. A representative experiment of three independent experiments is shown.</p></sec><sec id="s4-8"><title>Fluorescence in situ hybridization (FISH)</title><p>Visualization of mRNA and G<sub>4</sub>C<sub>2</sub> RNA by FISH was carried out as previously described (<xref ref-type="bibr" rid="bib92">Woerner et al., 2016</xref>). HEK293 cells were fixed in 4% formaldehyde for 10 min at room temperature and permeabilized with 0.1% Triton X-100, both in UltraPure SCC buffer (Thermo Fisher Scientific). After washing with SSC buffer and with FISH buffer (10% formamide in SCC buffer), the probes (either T30 or (C<sub>4</sub>G<sub>2</sub>)<sub>5</sub>) were hybridized in FISH buffer with 10% dextran sulphate (Sigma Aldrich) for 3 hr at 42°C, followed by additional washes in FISH buffer. When required, immunostaining was performed in PBS-based buffers afterward. The fraction of transfected cells displaying abnormal accumulation of mRNA (using poly-dT probe) within the nucleus was determined by confocal microscopy.</p></sec><sec id="s4-9"><title>Filter retardation assay</title><p>For the filter retardation assay (<xref ref-type="bibr" rid="bib68">Scherzinger et al., 1997</xref>; <xref ref-type="bibr" rid="bib87">Wanker et al., 1999</xref>), cells were harvested 24 hr after transfection with the indicated plasmids, lysed in radioimmunoprecipitation assay (RIPA) buffer (Thermo Fisher Scientific) and sonicated for 10 s. After incubation for 30 min, protein concentration was measured by Bradford assay (Bio-Rad), and equal amounts of lysates were filtered through a 0.2 µm pore size cellulose acetate membrane (GE Healthcare) and washed with lysis buffer. The membrane was subsequently immunoassayed with anti-GFP antibody. Antibody binding was detected using Luminata Forte Western HRP substrate (Millipore), and pictures were acquired with a LAS-3000 camera system (Fujifilm). AIDA (Raytest) software was used for analysis and quantitation.</p></sec><sec id="s4-10"><title>Statistics</title><p>Significance of differences between samples was determined using unpaired Student’s t-test, unless stated otherwise. Significance levels: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank R Klein, D Edbauer, R Körner, and R Sawarkar for helpful discussions. We acknowledge technical support by the MPIB Imaging facility. Funding: The research leading to these results has received funding from the European Commission under grant FP7 GA ERC-2012-SyG_318987–ToPAG. FF was supported by an EMBO Long Term Fellowship. MPB was supported by the Lehre@LMU Student Research Award Program of the Faculty of Biology at LMU Munich (sponsored by the Federal Ministry of Education and Research, funding no. 01PL17016).</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf2"><p>Reviewing editor, <italic>eLife</italic></p></fn><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Supervision, Investigation, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Supervision, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Supervision, Writing - original draft, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-62718-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Sarraj</surname> <given-names>S</given-names></name><name><surname>King</surname> <given-names>A</given-names></name><name><surname>Troakes</surname> <given-names>C</given-names></name><name><surname>Smith</surname> <given-names>B</given-names></name><name><surname>Maekawa</surname> <given-names>S</given-names></name><name><surname>Bodi</surname> <given-names>I</given-names></name><name><surname>Rogelj</surname> <given-names>B</given-names></name><name><surname>Al-Chalabi</surname> <given-names>A</given-names></name><name><surname>Hortobágyi</surname> <given-names>T</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and Hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS</article-title><source>Acta Neuropathologica</source><volume>122</volume><fpage>691</fpage><lpage>702</lpage><pub-id pub-id-type="doi">10.1007/s00401-011-0911-2</pub-id><pub-id pub-id-type="pmid">22101323</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Gascon</surname> <given-names>E</given-names></name><name><surname>Tran</surname> <given-names>H</given-names></name><name><surname>Chou</surname> <given-names>HJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Degroot</surname> <given-names>S</given-names></name><name><surname>Tapper</surname> <given-names>AR</given-names></name><name><surname>Sellier</surname> <given-names>C</given-names></name><name><surname>Charlet-Berguerand</surname> <given-names>N</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Seeley</surname> <given-names>WW</given-names></name><name><surname>Boxer</surname> <given-names>AL</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Modeling key pathological features of frontotemporal dementia with C9ORF72 repeat expansion in iPSC-derived human neurons</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>385</fpage><lpage>399</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1149-y</pub-id><pub-id pub-id-type="pmid">23836290</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>Lehmer</surname> <given-names>C</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>RNA versus protein toxicity in C9orf72 ALS/FTLD</article-title><source>Acta Neuropathologica</source><volume>135</volume><fpage>475</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1823-1</pub-id><pub-id pub-id-type="pmid">29450647</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Dejesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>van Blitterswijk</surname> <given-names>MM</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS</article-title><source>Neuron</source><volume>77</volume><fpage>639</fpage><lpage>646</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.02.004</pub-id><pub-id pub-id-type="pmid">23415312</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasio</surname> <given-names>A</given-names></name><name><surname>Decman</surname> <given-names>V</given-names></name><name><surname>White</surname> <given-names>D</given-names></name><name><surname>Ramos</surname> <given-names>M</given-names></name><name><surname>Ikiz</surname> <given-names>B</given-names></name><name><surname>Lee</surname> <given-names>HC</given-names></name><name><surname>Siao</surname> <given-names>CJ</given-names></name><name><surname>Brydges</surname> <given-names>S</given-names></name><name><surname>LaRosa</surname> <given-names>E</given-names></name><name><surname>Bai</surname> <given-names>Y</given-names></name><name><surname>Fury</surname> <given-names>W</given-names></name><name><surname>Burfeind</surname> <given-names>P</given-names></name><name><surname>Zamfirova</surname> <given-names>R</given-names></name><name><surname>Warshaw</surname> <given-names>G</given-names></name><name><surname>Orengo</surname> <given-names>J</given-names></name><name><surname>Oyejide</surname> <given-names>A</given-names></name><name><surname>Fralish</surname> <given-names>M</given-names></name><name><surname>Auerbach</surname> <given-names>W</given-names></name><name><surname>Poueymirou</surname> <given-names>W</given-names></name><name><surname>Freudenberg</surname> <given-names>J</given-names></name><name><surname>Gong</surname> <given-names>G</given-names></name><name><surname>Zambrowicz</surname> <given-names>B</given-names></name><name><surname>Valenzuela</surname> <given-names>D</given-names></name><name><surname>Yancopoulos</surname> <given-names>G</given-names></name><name><surname>Murphy</surname> <given-names>A</given-names></name><name><surname>Thurston</surname> <given-names>G</given-names></name><name><surname>Lai</surname> <given-names>KM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 ablation causes immune dysregulation characterized by leukocyte expansion, autoantibody production, and glomerulonephropathy in mice</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>23204</elocation-id><pub-id pub-id-type="doi">10.1038/srep23204</pub-id><pub-id pub-id-type="pmid">26979938</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balendra</surname> <given-names>R</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C9orf72-mediated ALS and FTD: multiple pathways to disease</article-title><source>Nature Reviews Neurology</source><volume>14</volume><fpage>544</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1038/s41582-018-0047-2</pub-id><pub-id pub-id-type="pmid">30120348</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Michiels</surname> <given-names>E</given-names></name><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>Sieben</surname> <given-names>A</given-names></name><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>De Baets</surname> <given-names>G</given-names></name><name><surname>Scheveneels</surname> <given-names>W</given-names></name><name><surname>Steyaert</surname> <given-names>J</given-names></name><name><surname>Cuijt</surname> <given-names>I</given-names></name><name><surname>Verstrepen</surname> <given-names>KJ</given-names></name><name><surname>Callaerts</surname> <given-names>P</given-names></name><name><surname>Rousseau</surname> <given-names>F</given-names></name><name><surname>Schymkowitz</surname> <given-names>J</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title><italic>Drosophila</italic> screen connects nuclear transport genes to DPR pathology in c9ALS/FTD</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>20877</elocation-id><pub-id pub-id-type="doi">10.1038/srep20877</pub-id><pub-id pub-id-type="pmid">26869068</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Kovacs</surname> <given-names>D</given-names></name><name><surname>Konijnenberg</surname> <given-names>A</given-names></name><name><surname>Timmerman</surname> <given-names>E</given-names></name><name><surname>Volkov</surname> <given-names>A</given-names></name><name><surname>Guharoy</surname> <given-names>M</given-names></name><name><surname>De Decker</surname> <given-names>M</given-names></name><name><surname>Jaspers</surname> <given-names>T</given-names></name><name><surname>Ryan</surname> <given-names>VH</given-names></name><name><surname>Janke</surname> <given-names>AM</given-names></name><name><surname>Baatsen</surname> <given-names>P</given-names></name><name><surname>Vercruysse</surname> <given-names>T</given-names></name><name><surname>Kolaitis</surname> <given-names>R-M</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Kedersha</surname> <given-names>N</given-names></name><name><surname>Anderson</surname> <given-names>P</given-names></name><name><surname>Impens</surname> <given-names>F</given-names></name><name><surname>Sobott</surname> <given-names>F</given-names></name><name><surname>Schymkowitz</surname> <given-names>J</given-names></name><name><surname>Rousseau</surname> <given-names>F</given-names></name><name><surname>Fawzi</surname> <given-names>NL</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Tompa</surname> <given-names>P</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Phase separation of C9orf72 dipeptide repeats perturbs stress granule dynamics</article-title><source>Molecular Cell</source><volume>65</volume><fpage>1044</fpage><lpage>1055</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.02.013</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boivin</surname> <given-names>M</given-names></name><name><surname>Pfister</surname> <given-names>V</given-names></name><name><surname>Gaucherot</surname> <given-names>A</given-names></name><name><surname>Ruffenach</surname> <given-names>F</given-names></name><name><surname>Negroni</surname> <given-names>L</given-names></name><name><surname>Sellier</surname> <given-names>C</given-names></name><name><surname>Charlet-Berguerand</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduced autophagy upon C9ORF72 loss synergizes with dipeptide repeat protein toxicity in G4C2 repeat expansion disorders</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e100574</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2018100574</pub-id><pub-id pub-id-type="pmid">31930538</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burberry</surname> <given-names>A</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>JY</given-names></name><name><surname>Moccia</surname> <given-names>R</given-names></name><name><surname>Mordes</surname> <given-names>DA</given-names></name><name><surname>Stewart</surname> <given-names>MH</given-names></name><name><surname>Suzuki-Uematsu</surname> <given-names>S</given-names></name><name><surname>Ghosh</surname> <given-names>S</given-names></name><name><surname>Singh</surname> <given-names>A</given-names></name><name><surname>Merkle</surname> <given-names>FT</given-names></name><name><surname>Koszka</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>QZ</given-names></name><name><surname>Zon</surname> <given-names>L</given-names></name><name><surname>Rossi</surname> <given-names>DJ</given-names></name><name><surname>Trowbridge</surname> <given-names>JJ</given-names></name><name><surname>Notarangelo</surname> <given-names>LD</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss-of-function mutations in the <italic>C9ORF72</italic> mouse ortholog cause fatal autoimmune disease</article-title><source>Science Translational Medicine</source><volume>8</volume><elocation-id>347ra93</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.aaf6038</pub-id><pub-id pub-id-type="pmid">27412785</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burberry</surname> <given-names>A</given-names></name><name><surname>Wells</surname> <given-names>MF</given-names></name><name><surname>Limone</surname> <given-names>F</given-names></name><name><surname>Couto</surname> <given-names>A</given-names></name><name><surname>Smith</surname> <given-names>KS</given-names></name><name><surname>Keaney</surname> <given-names>J</given-names></name><name><surname>Gillet</surname> <given-names>G</given-names></name><name><surname>van Gastel</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>JY</given-names></name><name><surname>Pietilainen</surname> <given-names>O</given-names></name><name><surname>Qian</surname> <given-names>M</given-names></name><name><surname>Eggan</surname> <given-names>P</given-names></name><name><surname>Cantrell</surname> <given-names>C</given-names></name><name><surname>Mok</surname> <given-names>J</given-names></name><name><surname>Kadiu</surname> <given-names>I</given-names></name><name><surname>Scadden</surname> <given-names>DT</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>C9orf72 suppresses systemic and neural inflammation induced by gut Bacteria</article-title><source>Nature</source><volume>582</volume><fpage>89</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-2288-7</pub-id><pub-id pub-id-type="pmid">32483373</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname> <given-names>KC</given-names></name><name><surname>Taneja</surname> <given-names>KL</given-names></name><name><surname>Lawrence</surname> <given-names>JB</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Discrete nuclear domains of poly(A) RNA and their relationship to the functional organization of the nucleus</article-title><source>The Journal of Cell Biology</source><volume>115</volume><fpage>1191</fpage><lpage>1202</lpage><pub-id pub-id-type="doi">10.1083/jcb.115.5.1191</pub-id><pub-id pub-id-type="pmid">1720123</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname> <given-names>CC</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>Umoh</surname> <given-names>ME</given-names></name><name><surname>Vaughan</surname> <given-names>SW</given-names></name><name><surname>Lorenzini</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>F</given-names></name><name><surname>Sayegh</surname> <given-names>M</given-names></name><name><surname>Donlin-Asp</surname> <given-names>PG</given-names></name><name><surname>Chen</surname> <given-names>YH</given-names></name><name><surname>Duong</surname> <given-names>DM</given-names></name><name><surname>Seyfried</surname> <given-names>NT</given-names></name><name><surname>Powers</surname> <given-names>MA</given-names></name><name><surname>Kukar</surname> <given-names>T</given-names></name><name><surname>Hales</surname> <given-names>CM</given-names></name><name><surname>Gearing</surname> <given-names>M</given-names></name><name><surname>Cairns</surname> <given-names>NJ</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Sattler</surname> <given-names>R</given-names></name><name><surname>Zarnescu</surname> <given-names>DC</given-names></name><name><surname>Glass</surname> <given-names>JD</given-names></name><name><surname>Rossoll</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD</article-title><source>Nature Neuroscience</source><volume>21</volume><fpage>228</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1038/s41593-017-0047-3</pub-id><pub-id pub-id-type="pmid">29311743</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname> <given-names>CN</given-names></name><name><surname>Wu</surname> <given-names>Y</given-names></name><name><surname>Odeh</surname> <given-names>HM</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Del Rosso</surname> <given-names>G</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Jiang</surname> <given-names>P</given-names></name><name><surname>Gomes</surname> <given-names>E</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Avendano</surname> <given-names>NM</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Shao</surname> <given-names>W</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Tomassy</surname> <given-names>GS</given-names></name><name><surname>McCampbell</surname> <given-names>A</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Shorter</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>C9orf72</italic> poly(GR) aggregation induces TDP-43 proteinopathy</article-title><source>Science Translational Medicine</source><volume>12</volume><elocation-id>eabb3774</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.abb3774</pub-id><pub-id pub-id-type="pmid">32878979</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-Knock</surname> <given-names>J</given-names></name><name><surname>Walsh</surname> <given-names>MJ</given-names></name><name><surname>Higginbottom</surname> <given-names>A</given-names></name><name><surname>Robin Highley</surname> <given-names>J</given-names></name><name><surname>Dickman</surname> <given-names>MJ</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Ince</surname> <given-names>PG</given-names></name><name><surname>Wharton</surname> <given-names>SB</given-names></name><name><surname>Wilson</surname> <given-names>SA</given-names></name><name><surname>Kirby</surname> <given-names>J</given-names></name><name><surname>Hautbergue</surname> <given-names>GM</given-names></name><name><surname>Shaw</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Sequestration of multiple RNA recognition motif-containing proteins by C9orf72 repeat expansions</article-title><source>Brain</source><volume>137</volume><fpage>2040</fpage><lpage>2051</lpage><pub-id pub-id-type="doi">10.1093/brain/awu120</pub-id><pub-id pub-id-type="pmid">24866055</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper-Knock</surname> <given-names>J</given-names></name><name><surname>Higginbottom</surname> <given-names>A</given-names></name><name><surname>Stopford</surname> <given-names>MJ</given-names></name><name><surname>Highley</surname> <given-names>JR</given-names></name><name><surname>Ince</surname> <given-names>PG</given-names></name><name><surname>Wharton</surname> <given-names>SB</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Kirby</surname> <given-names>J</given-names></name><name><surname>Hautbergue</surname> <given-names>GM</given-names></name><name><surname>Shaw</surname> <given-names>PJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antisense RNA foci in the motor neurons of C9ORF72-ALS patients are associated with TDP-43 proteinopathy</article-title><source>Acta Neuropathologica</source><volume>130</volume><fpage>63</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1429-9</pub-id><pub-id pub-id-type="pmid">25943887</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname> <given-names>Y</given-names></name><name><surname>Robinson</surname> <given-names>AC</given-names></name><name><surname>Liu</surname> <given-names>X</given-names></name><name><surname>Wu</surname> <given-names>D</given-names></name><name><surname>Troakes</surname> <given-names>C</given-names></name><name><surname>Rollinson</surname> <given-names>S</given-names></name><name><surname>Masuda-Suzukake</surname> <given-names>M</given-names></name><name><surname>Suzuki</surname> <given-names>G</given-names></name><name><surname>Nonaka</surname> <given-names>T</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Tian</surname> <given-names>J</given-names></name><name><surname>Hamdalla</surname> <given-names>H</given-names></name><name><surname>Ealing</surname> <given-names>J</given-names></name><name><surname>Richardson</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>M</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Snowden</surname> <given-names>JS</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name><name><surname>Mann</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins</article-title><source>Neuropathology and Applied Neurobiology</source><volume>42</volume><fpage>242</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1111/nan.12292</pub-id><pub-id pub-id-type="pmid">26538301</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeJesus-Hernandez</surname> <given-names>M</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Boeve</surname> <given-names>BF</given-names></name><name><surname>Boxer</surname> <given-names>AL</given-names></name><name><surname>Baker</surname> <given-names>M</given-names></name><name><surname>Rutherford</surname> <given-names>NJ</given-names></name><name><surname>Nicholson</surname> <given-names>AM</given-names></name><name><surname>Finch</surname> <given-names>NA</given-names></name><name><surname>Flynn</surname> <given-names>H</given-names></name><name><surname>Adamson</surname> <given-names>J</given-names></name><name><surname>Kouri</surname> <given-names>N</given-names></name><name><surname>Wojtas</surname> <given-names>A</given-names></name><name><surname>Sengdy</surname> <given-names>P</given-names></name><name><surname>Hsiung</surname> <given-names>GY</given-names></name><name><surname>Karydas</surname> <given-names>A</given-names></name><name><surname>Seeley</surname> <given-names>WW</given-names></name><name><surname>Josephs</surname> <given-names>KA</given-names></name><name><surname>Coppola</surname> <given-names>G</given-names></name><name><surname>Geschwind</surname> <given-names>DH</given-names></name><name><surname>Wszolek</surname> <given-names>ZK</given-names></name><name><surname>Feldman</surname> <given-names>H</given-names></name><name><surname>Knopman</surname> <given-names>DS</given-names></name><name><surname>Petersen</surname> <given-names>RC</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Graff-Radford</surname> <given-names>NR</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS</article-title><source>Neuron</source><volume>72</volume><fpage>245</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.011</pub-id><pub-id pub-id-type="pmid">21944778</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donnelly</surname> <given-names>CJ</given-names></name><name><surname>Zhang</surname> <given-names>PW</given-names></name><name><surname>Pham</surname> <given-names>JT</given-names></name><name><surname>Haeusler</surname> <given-names>AR</given-names></name><name><surname>Heusler</surname> <given-names>AR</given-names></name><name><surname>Mistry</surname> <given-names>NA</given-names></name><name><surname>Vidensky</surname> <given-names>S</given-names></name><name><surname>Daley</surname> <given-names>EL</given-names></name><name><surname>Poth</surname> <given-names>EM</given-names></name><name><surname>Hoover</surname> <given-names>B</given-names></name><name><surname>Fines</surname> <given-names>DM</given-names></name><name><surname>Maragakis</surname> <given-names>N</given-names></name><name><surname>Tienari</surname> <given-names>PJ</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Blackshaw</surname> <given-names>S</given-names></name><name><surname>Sattler</surname> <given-names>R</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention</article-title><source>Neuron</source><volume>80</volume><fpage>415</fpage><lpage>428</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2013.10.015</pub-id><pub-id pub-id-type="pmid">24139042</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dormann</surname> <given-names>D</given-names></name><name><surname>Rodde</surname> <given-names>R</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Bentmann</surname> <given-names>E</given-names></name><name><surname>Fischer</surname> <given-names>I</given-names></name><name><surname>Hruscha</surname> <given-names>A</given-names></name><name><surname>Than</surname> <given-names>ME</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Capell</surname> <given-names>A</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Neumann</surname> <given-names>M</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import</article-title><source>The EMBO Journal</source><volume>29</volume><fpage>2841</fpage><lpage>2857</lpage><pub-id pub-id-type="doi">10.1038/emboj.2010.143</pub-id><pub-id pub-id-type="pmid">20606625</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eftekharzadeh</surname> <given-names>B</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Kapinos</surname> <given-names>LE</given-names></name><name><surname>Coyne</surname> <given-names>A</given-names></name><name><surname>Schiantarelli</surname> <given-names>J</given-names></name><name><surname>Carlomagno</surname> <given-names>Y</given-names></name><name><surname>Cook</surname> <given-names>C</given-names></name><name><surname>Miller</surname> <given-names>SJ</given-names></name><name><surname>Dujardin</surname> <given-names>S</given-names></name><name><surname>Amaral</surname> <given-names>AS</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Bennett</surname> <given-names>RE</given-names></name><name><surname>Tepper</surname> <given-names>K</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Vanderburg</surname> <given-names>CR</given-names></name><name><surname>Corjuc</surname> <given-names>BT</given-names></name><name><surname>DeVos</surname> <given-names>SL</given-names></name><name><surname>Gonzalez</surname> <given-names>JA</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Vidensky</surname> <given-names>S</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Troncoso</surname> <given-names>J</given-names></name><name><surname>Mandelkow</surname> <given-names>E</given-names></name><name><surname>Salvatella</surname> <given-names>X</given-names></name><name><surname>Lim</surname> <given-names>RYH</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Wegmann</surname> <given-names>S</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Hyman</surname> <given-names>BT</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tau protein disrupts nucleocytoplasmic transport in Alzheimer's Disease</article-title><source>Neuron</source><volume>101</volume><elocation-id>349</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuron.2018.12.031</pub-id><pub-id pub-id-type="pmid">30653936</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Lopez-Gonzalez</surname> <given-names>R</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Lee</surname> <given-names>KH</given-names></name><name><surname>Badders</surname> <given-names>N</given-names></name><name><surname>Valentine</surname> <given-names>M</given-names></name><name><surname>Miller</surname> <given-names>BL</given-names></name><name><surname>Wong</surname> <given-names>PC</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="doi">10.1038/nature14974</pub-id><pub-id pub-id-type="pmid">26308899</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frottin</surname> <given-names>F</given-names></name><name><surname>Schueder</surname> <given-names>F</given-names></name><name><surname>Tiwary</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>R</given-names></name><name><surname>Körner</surname> <given-names>R</given-names></name><name><surname>Schlichthaerle</surname> <given-names>T</given-names></name><name><surname>Cox</surname> <given-names>J</given-names></name><name><surname>Jungmann</surname> <given-names>R</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The nucleolus functions as a phase-separated protein quality control compartment</article-title><source>Science</source><volume>365</volume><fpage>342</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1126/science.aaw9157</pub-id><pub-id pub-id-type="pmid">31296649</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gal</surname> <given-names>J</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Kwinter</surname> <given-names>DM</given-names></name><name><surname>Zhai</surname> <given-names>J</given-names></name><name><surname>Jia</surname> <given-names>H</given-names></name><name><surname>Jia</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Nuclear localization sequence of FUS and induction of stress granules by ALS mutants</article-title><source>Neurobiology of Aging</source><volume>32</volume><elocation-id>2323.e27</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2010.06.010</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasset-Rosa</surname> <given-names>F</given-names></name><name><surname>Chillon-Marinas</surname> <given-names>C</given-names></name><name><surname>Goginashvili</surname> <given-names>A</given-names></name><name><surname>Atwal</surname> <given-names>RS</given-names></name><name><surname>Artates</surname> <given-names>JW</given-names></name><name><surname>Tabet</surname> <given-names>R</given-names></name><name><surname>Wheeler</surname> <given-names>VC</given-names></name><name><surname>Bang</surname> <given-names>AG</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Polyglutamine-Expanded huntingtin exacerbates Age-Related disruption of nuclear integrity and nucleocytoplasmic transport</article-title><source>Neuron</source><volume>94</volume><fpage>48</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.027</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Daughrity</surname> <given-names>L</given-names></name><name><surname>Dunmore</surname> <given-names>JH</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Cosio</surname> <given-names>DM</given-names></name><name><surname>van Blitterswijk</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>WC</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>829</fpage><lpage>844</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1192-8</pub-id><pub-id pub-id-type="pmid">24129584</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>Van Mossevelde</surname> <given-names>S</given-names></name><name><surname>van der Zee</surname> <given-names>J</given-names></name><name><surname>Sieben</surname> <given-names>A</given-names></name><name><surname>Engelborghs</surname> <given-names>S</given-names></name><name><surname>De Bleecker</surname> <given-names>J</given-names></name><name><surname>Ivanoiu</surname> <given-names>A</given-names></name><name><surname>Deryck</surname> <given-names>O</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>M</given-names></name><name><surname>Heeman</surname> <given-names>B</given-names></name><name><surname>Bäumer</surname> <given-names>V</given-names></name><name><surname>Van den Broeck</surname> <given-names>M</given-names></name><name><surname>Mattheijssens</surname> <given-names>M</given-names></name><name><surname>Peeters</surname> <given-names>K</given-names></name><name><surname>Rogaeva</surname> <given-names>E</given-names></name><name><surname>De Jonghe</surname> <given-names>P</given-names></name><name><surname>Cras</surname> <given-names>P</given-names></name><name><surname>Martin</surname> <given-names>JJ</given-names></name><name><surname>de Deyn</surname> <given-names>PP</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter</article-title><source>Molecular Psychiatry</source><volume>21</volume><fpage>1112</fpage><lpage>1124</lpage><pub-id pub-id-type="doi">10.1038/mp.2015.159</pub-id><pub-id pub-id-type="pmid">26481318</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Tsuiji</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>There has been an awakening: emerging mechanisms of C9orf72 mutations in FTD/ALS</article-title><source>Brain Research</source><volume>1647</volume><fpage>19</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2016.04.004</pub-id><pub-id pub-id-type="pmid">27059391</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Arbez</surname> <given-names>N</given-names></name><name><surname>Cunningham</surname> <given-names>KC</given-names></name><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Ochaba</surname> <given-names>J</given-names></name><name><surname>Geater</surname> <given-names>C</given-names></name><name><surname>Morozko</surname> <given-names>E</given-names></name><name><surname>Stocksdale</surname> <given-names>J</given-names></name><name><surname>Glatzer</surname> <given-names>JC</given-names></name><name><surname>Pham</surname> <given-names>JT</given-names></name><name><surname>Ahmed</surname> <given-names>I</given-names></name><name><surname>Peng</surname> <given-names>Q</given-names></name><name><surname>Wadhwa</surname> <given-names>H</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Duan</surname> <given-names>W</given-names></name><name><surname>Snyder</surname> <given-names>SH</given-names></name><name><surname>Ranum</surname> <given-names>LPW</given-names></name><name><surname>Thompson</surname> <given-names>LM</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name><name><surname>Ross</surname> <given-names>CA</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mutant huntingtin disrupts the nuclear pore complex</article-title><source>Neuron</source><volume>94</volume><fpage>93</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.03.023</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname> <given-names>Q</given-names></name><name><surname>Lehmer</surname> <given-names>C</given-names></name><name><surname>Martínez-Sánchez</surname> <given-names>A</given-names></name><name><surname>Rudack</surname> <given-names>T</given-names></name><name><surname>Beck</surname> <given-names>F</given-names></name><name><surname>Hartmann</surname> <given-names>H</given-names></name><name><surname>Pérez-Berlanga</surname> <given-names>M</given-names></name><name><surname>Frottin</surname> <given-names>F</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Baumeister</surname> <given-names>W</given-names></name><name><surname>Fernández-Busnadiego</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>In situ structure of neuronal C9orf72 Poly-GA aggregates reveals proteasome recruitment</article-title><source>Cell</source><volume>172</volume><fpage>696</fpage><lpage>705</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.12.030</pub-id><pub-id pub-id-type="pmid">29398115</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haeusler</surname> <given-names>AR</given-names></name><name><surname>Donnelly</surname> <given-names>CJ</given-names></name><name><surname>Periz</surname> <given-names>G</given-names></name><name><surname>Simko</surname> <given-names>EA</given-names></name><name><surname>Shaw</surname> <given-names>PG</given-names></name><name><surname>Kim</surname> <given-names>MS</given-names></name><name><surname>Maragakis</surname> <given-names>NJ</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Pandey</surname> <given-names>A</given-names></name><name><surname>Sattler</surname> <given-names>R</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9orf72 nucleotide repeat structures initiate molecular cascades of disease</article-title><source>Nature</source><volume>507</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1038/nature13124</pub-id><pub-id pub-id-type="pmid">24598541</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayes</surname> <given-names>LR</given-names></name><name><surname>Duan</surname> <given-names>L</given-names></name><name><surname>Bowen</surname> <given-names>K</given-names></name><name><surname>Kalab</surname> <given-names>P</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title><italic>C9orf72</italic> arginine-rich dipeptide repeat proteins disrupt karyopherin-mediated nuclear import</article-title><source>eLife</source><volume>9</volume><elocation-id>e51685</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.51685</pub-id><pub-id pub-id-type="pmid">32119645</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Saberi</surname> <given-names>S</given-names></name><name><surname>McAlonis-Downes</surname> <given-names>M</given-names></name><name><surname>Seelman</surname> <given-names>A</given-names></name><name><surname>Stauffer</surname> <given-names>JE</given-names></name><name><surname>Jafar-Nejad</surname> <given-names>P</given-names></name><name><surname>Drenner</surname> <given-names>K</given-names></name><name><surname>Schulte</surname> <given-names>D</given-names></name><name><surname>Chun</surname> <given-names>S</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Ling</surname> <given-names>SC</given-names></name><name><surname>Myers</surname> <given-names>B</given-names></name><name><surname>Engelhardt</surname> <given-names>J</given-names></name><name><surname>Katz</surname> <given-names>M</given-names></name><name><surname>Baughn</surname> <given-names>M</given-names></name><name><surname>Platoshyn</surname> <given-names>O</given-names></name><name><surname>Marsala</surname> <given-names>M</given-names></name><name><surname>Watt</surname> <given-names>A</given-names></name><name><surname>Heyser</surname> <given-names>CJ</given-names></name><name><surname>Ard</surname> <given-names>MC</given-names></name><name><surname>De Muynck</surname> <given-names>L</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Swing</surname> <given-names>DA</given-names></name><name><surname>Tessarollo</surname> <given-names>L</given-names></name><name><surname>Jung</surname> <given-names>CJ</given-names></name><name><surname>Delpoux</surname> <given-names>A</given-names></name><name><surname>Utzschneider</surname> <given-names>DT</given-names></name><name><surname>Hedrick</surname> <given-names>SM</given-names></name><name><surname>de Jong</surname> <given-names>PJ</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Da Cruz</surname> <given-names>S</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Gain of toxicity from ALS/FTD-Linked repeat expansions in C9ORF72 is alleviated by antisense oligonucleotides targeting GGGGCC-Containing RNAs</article-title><source>Neuron</source><volume>90</volume><fpage>535</fpage><lpage>550</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.006</pub-id><pub-id pub-id-type="pmid">27112497</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Pathogenic mechanisms and therapy development for C9orf72 amyotrophic lateral sclerosis/Frontotemporal dementia</article-title><source>Neurotherapeutics</source><volume>16</volume><fpage>1115</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1007/s13311-019-00797-2</pub-id><pub-id pub-id-type="pmid">31667754</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>Mertens</surname> <given-names>J</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Chai</surname> <given-names>N</given-names></name><name><surname>Yamada</surname> <given-names>SB</given-names></name><name><surname>Paul</surname> <given-names>JW</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Herdy</surname> <given-names>JR</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Kramer</surname> <given-names>NJ</given-names></name><name><surname>Gage</surname> <given-names>FH</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS</article-title><source>Nature Neuroscience</source><volume>18</volume><fpage>1226</fpage><lpage>1229</lpage><pub-id pub-id-type="doi">10.1038/nn.4085</pub-id><pub-id pub-id-type="pmid">26308983</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanekura</surname> <given-names>K</given-names></name><name><surname>Yagi</surname> <given-names>T</given-names></name><name><surname>Cammack</surname> <given-names>AJ</given-names></name><name><surname>Mahadevan</surname> <given-names>J</given-names></name><name><surname>Kuroda</surname> <given-names>M</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Urano</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation</article-title><source>Human Molecular Genetics</source><volume>25</volume><fpage>1803</fpage><lpage>1813</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw052</pub-id><pub-id pub-id-type="pmid">26931465</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kayed</surname> <given-names>R</given-names></name><name><surname>Head</surname> <given-names>E</given-names></name><name><surname>Sarsoza</surname> <given-names>F</given-names></name><name><surname>Saing</surname> <given-names>T</given-names></name><name><surname>Cotman</surname> <given-names>CW</given-names></name><name><surname>Necula</surname> <given-names>M</given-names></name><name><surname>Margol</surname> <given-names>L</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Breydo</surname> <given-names>L</given-names></name><name><surname>Thompson</surname> <given-names>JL</given-names></name><name><surname>Rasool</surname> <given-names>S</given-names></name><name><surname>Gurlo</surname> <given-names>T</given-names></name><name><surname>Butler</surname> <given-names>P</given-names></name><name><surname>Glabe</surname> <given-names>CG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers</article-title><source>Molecular Neurodegeneration</source><volume>2</volume><elocation-id>18</elocation-id><pub-id pub-id-type="doi">10.1186/1750-1326-2-18</pub-id><pub-id pub-id-type="pmid">17897471</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname> <given-names>B</given-names></name><name><surname>Hartmann</surname> <given-names>H</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Möhl</surname> <given-names>C</given-names></name><name><surname>Ederle</surname> <given-names>H</given-names></name><name><surname>Michaelsen</surname> <given-names>M</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>Dormann</surname> <given-names>D</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Feb 15). Cytoplasmic poly-GA aggregates impair nuclear import of TDP-43 in C9orf72 ALS/FTLD</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>790</fpage><lpage>800</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddw432</pub-id><pub-id pub-id-type="pmid">28040728</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khosravi</surname> <given-names>B</given-names></name><name><surname>LaClair</surname> <given-names>KD</given-names></name><name><surname>Riemenschneider</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Frottin</surname> <given-names>F</given-names></name><name><surname>Mareljic</surname> <given-names>N</given-names></name><name><surname>Czuppa</surname> <given-names>M</given-names></name><name><surname>Farny</surname> <given-names>D</given-names></name><name><surname>Hartmann</surname> <given-names>H</given-names></name><name><surname>Michaelsen</surname> <given-names>M</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD</article-title><source>The EMBO Journal</source><volume>39</volume><elocation-id>e102811</elocation-id><pub-id pub-id-type="doi">10.15252/embj.2019102811</pub-id><pub-id pub-id-type="pmid">32175624</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koppers</surname> <given-names>M</given-names></name><name><surname>Blokhuis</surname> <given-names>AM</given-names></name><name><surname>Westeneng</surname> <given-names>HJ</given-names></name><name><surname>Terpstra</surname> <given-names>ML</given-names></name><name><surname>Zundel</surname> <given-names>CA</given-names></name><name><surname>Vieira de Sá</surname> <given-names>R</given-names></name><name><surname>Schellevis</surname> <given-names>RD</given-names></name><name><surname>Waite</surname> <given-names>AJ</given-names></name><name><surname>Blake</surname> <given-names>DJ</given-names></name><name><surname>Veldink</surname> <given-names>JH</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits</article-title><source>Annals of Neurology</source><volume>78</volume><fpage>426</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1002/ana.24453</pub-id><pub-id pub-id-type="pmid">26044557</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kramer</surname> <given-names>NJ</given-names></name><name><surname>Haney</surname> <given-names>MS</given-names></name><name><surname>Morgens</surname> <given-names>DW</given-names></name><name><surname>Jovičić</surname> <given-names>A</given-names></name><name><surname>Couthouis</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Ousey</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>R</given-names></name><name><surname>Bieri</surname> <given-names>G</given-names></name><name><surname>Tsui</surname> <given-names>CK</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Hertz</surname> <given-names>NT</given-names></name><name><surname>Tessier-Lavigne</surname> <given-names>M</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name><name><surname>Bassik</surname> <given-names>MC</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>CRISPR-Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity</article-title><source>Nature Genetics</source><volume>50</volume><fpage>603</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0070-7</pub-id><pub-id pub-id-type="pmid">29507424</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname> <given-names>I</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Theodoropoulos</surname> <given-names>P</given-names></name><name><surname>Wang</surname> <given-names>T</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Yun</surname> <given-names>J</given-names></name><name><surname>Xie</surname> <given-names>Y</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells</article-title><source>Science</source><volume>345</volume><fpage>1139</fpage><lpage>1145</lpage><pub-id pub-id-type="doi">10.1126/science.1254917</pub-id><pub-id pub-id-type="pmid">25081482</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Baughn</surname> <given-names>M</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Sun</surname> <given-names>S</given-names></name><name><surname>Liu</surname> <given-names>P</given-names></name><name><surname>Li</surname> <given-names>HR</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Watt</surname> <given-names>AT</given-names></name><name><surname>Chun</surname> <given-names>S</given-names></name><name><surname>Katz</surname> <given-names>M</given-names></name><name><surname>Qiu</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Ling</surname> <given-names>SC</given-names></name><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Polymenidou</surname> <given-names>M</given-names></name><name><surname>Drenner</surname> <given-names>K</given-names></name><name><surname>Artates</surname> <given-names>JW</given-names></name><name><surname>McAlonis-Downes</surname> <given-names>M</given-names></name><name><surname>Markmiller</surname> <given-names>S</given-names></name><name><surname>Hutt</surname> <given-names>KR</given-names></name><name><surname>Pizzo</surname> <given-names>DP</given-names></name><name><surname>Cady</surname> <given-names>J</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Baloh</surname> <given-names>RH</given-names></name><name><surname>Vandenberg</surname> <given-names>SR</given-names></name><name><surname>Yeo</surname> <given-names>GW</given-names></name><name><surname>Fu</surname> <given-names>XD</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration</article-title><source>PNAS</source><volume>110</volume><fpage>E4530</fpage><lpage>E4539</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318835110</pub-id><pub-id pub-id-type="pmid">24170860</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>K-H</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Kim</surname> <given-names>HJ</given-names></name><name><surname>Mitrea</surname> <given-names>DM</given-names></name><name><surname>Sarkar</surname> <given-names>M</given-names></name><name><surname>Freibaum</surname> <given-names>BD</given-names></name><name><surname>Cika</surname> <given-names>J</given-names></name><name><surname>Coughlin</surname> <given-names>M</given-names></name><name><surname>Messing</surname> <given-names>J</given-names></name><name><surname>Molliex</surname> <given-names>A</given-names></name><name><surname>Maxwell</surname> <given-names>BA</given-names></name><name><surname>Kim</surname> <given-names>NC</given-names></name><name><surname>Temirov</surname> <given-names>J</given-names></name><name><surname>Moore</surname> <given-names>J</given-names></name><name><surname>Kolaitis</surname> <given-names>R-M</given-names></name><name><surname>Shaw</surname> <given-names>TI</given-names></name><name><surname>Bai</surname> <given-names>B</given-names></name><name><surname>Peng</surname> <given-names>J</given-names></name><name><surname>Kriwacki</surname> <given-names>RW</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 dipeptide repeats impair the assembly, dynamics, and function of Membrane-Less organelles</article-title><source>Cell</source><volume>167</volume><fpage>774</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.002</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>YB</given-names></name><name><surname>Baskaran</surname> <given-names>P</given-names></name><name><surname>Gomez-Deza</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>HJ</given-names></name><name><surname>Nishimura</surname> <given-names>AL</given-names></name><name><surname>Smith</surname> <given-names>BN</given-names></name><name><surname>Troakes</surname> <given-names>C</given-names></name><name><surname>Adachi</surname> <given-names>Y</given-names></name><name><surname>Stepto</surname> <given-names>A</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Gallo</surname> <given-names>JM</given-names></name><name><surname>Hirth</surname> <given-names>F</given-names></name><name><surname>Rogelj</surname> <given-names>B</given-names></name><name><surname>Guthrie</surname> <given-names>S</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>C9orf72 poly GA RAN-translated protein plays a key role in amyotrophic lateral sclerosis via aggregation and toxicity</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>4765</fpage><lpage>4777</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx350</pub-id><pub-id pub-id-type="pmid">28973350</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>L</given-names></name><name><surname>Kwon</surname> <given-names>I</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Toxic PR Poly-Dipeptides encoded by the C9orf72 repeat expansion target LC domain polymers</article-title><source>Cell</source><volume>167</volume><fpage>789</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.003</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Pattamatta</surname> <given-names>A</given-names></name><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Reid</surname> <given-names>T</given-names></name><name><surname>Bardhi</surname> <given-names>O</given-names></name><name><surname>Borchelt</surname> <given-names>DR</given-names></name><name><surname>Yachnis</surname> <given-names>AT</given-names></name><name><surname>Ranum</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD</article-title><source>Neuron</source><volume>90</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.005</pub-id><pub-id pub-id-type="pmid">27112499</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Frick</surname> <given-names>P</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Cashman</surname> <given-names>NR</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Prudlo</surname> <given-names>J</given-names></name><name><surname>Troost</surname> <given-names>D</given-names></name><name><surname>Neumann</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers</article-title><source>Acta Neuropathologica</source><volume>130</volume><fpage>845</fpage><lpage>861</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1476-2</pub-id><pub-id pub-id-type="pmid">26374446</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Hornburg</surname> <given-names>D</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Schwenk</surname> <given-names>BM</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Banzhaf-Strathmann</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration</article-title><source>Acta Neuropathologica</source><volume>128</volume><fpage>485</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1329-4</pub-id><pub-id pub-id-type="pmid">25120191</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizielinska</surname> <given-names>S</given-names></name><name><surname>Ridler</surname> <given-names>CE</given-names></name><name><surname>Balendra</surname> <given-names>R</given-names></name><name><surname>Thoeng</surname> <given-names>A</given-names></name><name><surname>Woodling</surname> <given-names>NS</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Plagnol</surname> <given-names>V</given-names></name><name><surname>Lashley</surname> <given-names>T</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Bidirectional nucleolar dysfunction in C9orf72 frontotemporal lobar degeneration</article-title><source>Acta Neuropathologica Communications</source><volume>5</volume><elocation-id>29</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-017-0432-x</pub-id><pub-id pub-id-type="pmid">28420437</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moens</surname> <given-names>TG</given-names></name><name><surname>Niccoli</surname> <given-names>T</given-names></name><name><surname>Wilson</surname> <given-names>KM</given-names></name><name><surname>Atilano</surname> <given-names>ML</given-names></name><name><surname>Birsa</surname> <given-names>N</given-names></name><name><surname>Gittings</surname> <given-names>LM</given-names></name><name><surname>Holbling</surname> <given-names>BV</given-names></name><name><surname>Dyson</surname> <given-names>MC</given-names></name><name><surname>Thoeng</surname> <given-names>A</given-names></name><name><surname>Neeves</surname> <given-names>J</given-names></name><name><surname>Glaria</surname> <given-names>I</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Bussmann</surname> <given-names>J</given-names></name><name><surname>Storkebaum</surname> <given-names>E</given-names></name><name><surname>Pardo</surname> <given-names>M</given-names></name><name><surname>Choudhary</surname> <given-names>JS</given-names></name><name><surname>Fratta</surname> <given-names>P</given-names></name><name><surname>Partridge</surname> <given-names>L</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9orf72 arginine-rich dipeptide proteins interact with ribosomal proteins in vivo to induce a toxic translational arrest that is rescued by eIF1A</article-title><source>Acta Neuropathologica</source><volume>137</volume><fpage>487</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1946-4</pub-id><pub-id pub-id-type="pmid">30604225</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Gijselinck</surname> <given-names>I</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>SM</given-names></name><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>van der Zee</surname> <given-names>J</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins</article-title><source>Acta Neuropathologica</source><volume>126</volume><fpage>881</fpage><lpage>893</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1189-3</pub-id><pub-id pub-id-type="pmid">24132570</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Lammich</surname> <given-names>S</given-names></name><name><surname>Mackenzie</surname> <given-names>IR</given-names></name><name><surname>Forné</surname> <given-names>I</given-names></name><name><surname>Zilow</surname> <given-names>S</given-names></name><name><surname>Kretzschmar</surname> <given-names>H</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Janssens</surname> <given-names>J</given-names></name><name><surname>Kleinberger</surname> <given-names>G</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Herms</surname> <given-names>J</given-names></name><name><surname>Neumann</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the Hippocampus of patients with C9orf72 mutations</article-title><source>Acta Neuropathologica</source><volume>125</volume><fpage>413</fpage><lpage>423</lpage><pub-id pub-id-type="doi">10.1007/s00401-013-1088-7</pub-id><pub-id pub-id-type="pmid">23381195</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Weng</surname> <given-names>SM</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Kretzschmar</surname> <given-names>HA</given-names></name><name><surname>Cruts</surname> <given-names>M</given-names></name><name><surname>Van Broeckhoven</surname> <given-names>C</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013c</year><article-title>The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS</article-title><source>Science</source><volume>339</volume><fpage>1335</fpage><lpage>1338</lpage><pub-id pub-id-type="doi">10.1126/science.1232927</pub-id><pub-id pub-id-type="pmid">23393093</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nihei</surname> <given-names>Y</given-names></name><name><surname>Mori</surname> <given-names>K</given-names></name><name><surname>Werner</surname> <given-names>G</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Zhou</surname> <given-names>Q</given-names></name><name><surname>Khosravi</surname> <given-names>B</given-names></name><name><surname>Japtok</surname> <given-names>J</given-names></name><name><surname>Hermann</surname> <given-names>A</given-names></name><name><surname>Sommacal</surname> <given-names>A</given-names></name><name><surname>Weber</surname> <given-names>M</given-names></name><name><surname>Kamp</surname> <given-names>F</given-names></name><name><surname>Nuscher</surname> <given-names>B</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><collab>German Consortium for Frontotemporal Lobar Degeneration</collab><collab>Bavarian Brain Banking Alliance</collab></person-group><year iso-8601-date="2020">2020</year><article-title>Poly-glycine-alanine exacerbates C9orf72 repeat expansion-mediated DNA damage via sequestration of phosphorylated ATM and loss of nuclear hnRNPA3</article-title><source>Acta Neuropathologica</source><volume>139</volume><fpage>99</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1007/s00401-019-02082-0</pub-id><pub-id pub-id-type="pmid">31642962</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nonaka</surname> <given-names>T</given-names></name><name><surname>Masuda-Suzukake</surname> <given-names>M</given-names></name><name><surname>Hosokawa</surname> <given-names>M</given-names></name><name><surname>Shimozawa</surname> <given-names>A</given-names></name><name><surname>Hirai</surname> <given-names>S</given-names></name><name><surname>Okado</surname> <given-names>H</given-names></name><name><surname>Hasegawa</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>C9ORF72 dipeptide repeat poly-GA inclusions promote intracellular aggregation of phosphorylated TDP-43</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>2658</fpage><lpage>2670</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddy174</pub-id><pub-id pub-id-type="pmid">29750243</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nordin</surname> <given-names>A</given-names></name><name><surname>Akimoto</surname> <given-names>C</given-names></name><name><surname>Wuolikainen</surname> <given-names>A</given-names></name><name><surname>Alstermark</surname> <given-names>H</given-names></name><name><surname>Jonsson</surname> <given-names>P</given-names></name><name><surname>Birve</surname> <given-names>A</given-names></name><name><surname>Marklund</surname> <given-names>SL</given-names></name><name><surname>Graffmo</surname> <given-names>KS</given-names></name><name><surname>Forsberg</surname> <given-names>K</given-names></name><name><surname>Brännström</surname> <given-names>T</given-names></name><name><surname>Andersen</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Extensive size variability of the GGGGCC expansion in C9orf72 in both neuronal and non-neuronal tissues in 18 patients with ALS or FTD</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>3133</fpage><lpage>3142</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv064</pub-id><pub-id pub-id-type="pmid">25712133</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Rourke</surname> <given-names>JG</given-names></name><name><surname>Bogdanik</surname> <given-names>L</given-names></name><name><surname>Yáñez</surname> <given-names>A</given-names></name><name><surname>Lall</surname> <given-names>D</given-names></name><name><surname>Wolf</surname> <given-names>AJ</given-names></name><name><surname>Muhammad</surname> <given-names>AK</given-names></name><name><surname>Ho</surname> <given-names>R</given-names></name><name><surname>Carmona</surname> <given-names>S</given-names></name><name><surname>Vit</surname> <given-names>JP</given-names></name><name><surname>Zarrow</surname> <given-names>J</given-names></name><name><surname>Kim</surname> <given-names>KJ</given-names></name><name><surname>Bell</surname> <given-names>S</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Dangler</surname> <given-names>CA</given-names></name><name><surname>Underhill</surname> <given-names>DM</given-names></name><name><surname>Goodridge</surname> <given-names>HS</given-names></name><name><surname>Lutz</surname> <given-names>CM</given-names></name><name><surname>Baloh</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 is required for proper macrophage and microglial function in mice</article-title><source>Science</source><volume>351</volume><fpage>1324</fpage><lpage>1329</lpage><pub-id pub-id-type="doi">10.1126/science.aaf1064</pub-id><pub-id pub-id-type="pmid">26989253</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohki</surname> <given-names>Y</given-names></name><name><surname>Wenninger-Weinzierl</surname> <given-names>A</given-names></name><name><surname>Hruscha</surname> <given-names>A</given-names></name><name><surname>Asakawa</surname> <given-names>K</given-names></name><name><surname>Kawakami</surname> <given-names>K</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Glycine-alanine dipeptide repeat protein contributes to toxicity in a zebrafish model of C9orf72 associated neurodegeneration</article-title><source>Molecular Neurodegeneration</source><volume>12</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.1186/s13024-016-0146-8</pub-id><pub-id pub-id-type="pmid">28088213</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panda</surname> <given-names>SK</given-names></name><name><surname>Wefers</surname> <given-names>B</given-names></name><name><surname>Ortiz</surname> <given-names>O</given-names></name><name><surname>Floss</surname> <given-names>T</given-names></name><name><surname>Schmid</surname> <given-names>B</given-names></name><name><surname>Haass</surname> <given-names>C</given-names></name><name><surname>Wurst</surname> <given-names>W</given-names></name><name><surname>Kühn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Highly efficient targeted mutagenesis in mice using TALENs</article-title><source>Genetics</source><volume>195</volume><fpage>703</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1534/genetics.113.156570</pub-id><pub-id pub-id-type="pmid">23979585</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radwan</surname> <given-names>M</given-names></name><name><surname>Ang</surname> <given-names>CS</given-names></name><name><surname>Ormsby</surname> <given-names>AR</given-names></name><name><surname>Cox</surname> <given-names>D</given-names></name><name><surname>Daly</surname> <given-names>JC</given-names></name><name><surname>Reid</surname> <given-names>GE</given-names></name><name><surname>Hatters</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Arginine in <italic>C9ORF72</italic> dipolypeptides mediates promiscuous proteome binding and multiple modes of toxicity</article-title><source>Molecular &amp; Cellular Proteomics</source><volume>19</volume><fpage>640</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1074/mcp.RA119.001888</pub-id><pub-id pub-id-type="pmid">32086375</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname> <given-names>K</given-names></name><name><surname>Zamiri</surname> <given-names>B</given-names></name><name><surname>Stanley</surname> <given-names>SYR</given-names></name><name><surname>Macgregor</surname> <given-names>RB</given-names></name><name><surname>Pearson</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The disease-associated r(GGGGCC)n repeat from the C9orf72 gene forms tract length-dependent uni- and multimolecular RNA G-quadruplex structures</article-title><source>Journal of Biological Chemistry</source><volume>288</volume><fpage>9860</fpage><lpage>9866</lpage><pub-id pub-id-type="doi">10.1074/jbc.C113.452532</pub-id><pub-id pub-id-type="pmid">23423380</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renton</surname> <given-names>AE</given-names></name><name><surname>Majounie</surname> <given-names>E</given-names></name><name><surname>Waite</surname> <given-names>A</given-names></name><name><surname>Simón-Sánchez</surname> <given-names>J</given-names></name><name><surname>Rollinson</surname> <given-names>S</given-names></name><name><surname>Gibbs</surname> <given-names>JR</given-names></name><name><surname>Schymick</surname> <given-names>JC</given-names></name><name><surname>Laaksovirta</surname> <given-names>H</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name><name><surname>Myllykangas</surname> <given-names>L</given-names></name><name><surname>Kalimo</surname> <given-names>H</given-names></name><name><surname>Paetau</surname> <given-names>A</given-names></name><name><surname>Abramzon</surname> <given-names>Y</given-names></name><name><surname>Remes</surname> <given-names>AM</given-names></name><name><surname>Kaganovich</surname> <given-names>A</given-names></name><name><surname>Scholz</surname> <given-names>SW</given-names></name><name><surname>Duckworth</surname> <given-names>J</given-names></name><name><surname>Ding</surname> <given-names>J</given-names></name><name><surname>Harmer</surname> <given-names>DW</given-names></name><name><surname>Hernandez</surname> <given-names>DG</given-names></name><name><surname>Johnson</surname> <given-names>JO</given-names></name><name><surname>Mok</surname> <given-names>K</given-names></name><name><surname>Ryten</surname> <given-names>M</given-names></name><name><surname>Trabzuni</surname> <given-names>D</given-names></name><name><surname>Guerreiro</surname> <given-names>RJ</given-names></name><name><surname>Orrell</surname> <given-names>RW</given-names></name><name><surname>Neal</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>A</given-names></name><name><surname>Pearson</surname> <given-names>J</given-names></name><name><surname>Jansen</surname> <given-names>IE</given-names></name><name><surname>Sondervan</surname> <given-names>D</given-names></name><name><surname>Seelaar</surname> <given-names>H</given-names></name><name><surname>Blake</surname> <given-names>D</given-names></name><name><surname>Young</surname> <given-names>K</given-names></name><name><surname>Halliwell</surname> <given-names>N</given-names></name><name><surname>Callister</surname> <given-names>JB</given-names></name><name><surname>Toulson</surname> <given-names>G</given-names></name><name><surname>Richardson</surname> <given-names>A</given-names></name><name><surname>Gerhard</surname> <given-names>A</given-names></name><name><surname>Snowden</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>D</given-names></name><name><surname>Neary</surname> <given-names>D</given-names></name><name><surname>Nalls</surname> <given-names>MA</given-names></name><name><surname>Peuralinna</surname> <given-names>T</given-names></name><name><surname>Jansson</surname> <given-names>L</given-names></name><name><surname>Isoviita</surname> <given-names>VM</given-names></name><name><surname>Kaivorinne</surname> <given-names>AL</given-names></name><name><surname>Hölttä-Vuori</surname> <given-names>M</given-names></name><name><surname>Ikonen</surname> <given-names>E</given-names></name><name><surname>Sulkava</surname> <given-names>R</given-names></name><name><surname>Benatar</surname> <given-names>M</given-names></name><name><surname>Wuu</surname> <given-names>J</given-names></name><name><surname>Chiò</surname> <given-names>A</given-names></name><name><surname>Restagno</surname> <given-names>G</given-names></name><name><surname>Borghero</surname> <given-names>G</given-names></name><name><surname>Sabatelli</surname> <given-names>M</given-names></name><name><surname>Heckerman</surname> <given-names>D</given-names></name><name><surname>Rogaeva</surname> <given-names>E</given-names></name><name><surname>Zinman</surname> <given-names>L</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Sendtner</surname> <given-names>M</given-names></name><name><surname>Drepper</surname> <given-names>C</given-names></name><name><surname>Eichler</surname> <given-names>EE</given-names></name><name><surname>Alkan</surname> <given-names>C</given-names></name><name><surname>Abdullaev</surname> <given-names>Z</given-names></name><name><surname>Pack</surname> <given-names>SD</given-names></name><name><surname>Dutra</surname> <given-names>A</given-names></name><name><surname>Pak</surname> <given-names>E</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Singleton</surname> <given-names>A</given-names></name><name><surname>Williams</surname> <given-names>NM</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name><name><surname>Morris</surname> <given-names>HR</given-names></name><name><surname>Tienari</surname> <given-names>PJ</given-names></name><name><surname>Traynor</surname> <given-names>BJ</given-names></name><collab>ITALSGEN Consortium</collab></person-group><year iso-8601-date="2011">2011</year><article-title>A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD</article-title><source>Neuron</source><volume>72</volume><fpage>257</fpage><lpage>268</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.010</pub-id><pub-id pub-id-type="pmid">21944779</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riemslagh</surname> <given-names>FW</given-names></name><name><surname>Lans</surname> <given-names>H</given-names></name><name><surname>Seelaar</surname> <given-names>H</given-names></name><name><surname>Severijnen</surname> <given-names>L</given-names></name><name><surname>Melhem</surname> <given-names>S</given-names></name><name><surname>Vermeulen</surname> <given-names>W</given-names></name><name><surname>Aronica</surname> <given-names>E</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name><name><surname>Willemsen</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>HR23B pathology preferentially co-localizes with p62, pTDP-43 and poly-GA in C9ORF72-linked frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Acta Neuropathologica Communications</source><volume>7</volume><elocation-id>39</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-019-0694-6</pub-id><pub-id pub-id-type="pmid">30867060</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizzu</surname> <given-names>P</given-names></name><name><surname>Blauwendraat</surname> <given-names>C</given-names></name><name><surname>Heetveld</surname> <given-names>S</given-names></name><name><surname>Lynes</surname> <given-names>EM</given-names></name><name><surname>Castillo-Lizardo</surname> <given-names>M</given-names></name><name><surname>Dhingra</surname> <given-names>A</given-names></name><name><surname>Pyz</surname> <given-names>E</given-names></name><name><surname>Hobert</surname> <given-names>M</given-names></name><name><surname>Synofzik</surname> <given-names>M</given-names></name><name><surname>Simón-Sánchez</surname> <given-names>J</given-names></name><name><surname>Francescatto</surname> <given-names>M</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 is differentially expressed in the central nervous system and myeloid cells and consistently reduced in C9orf72, MAPT and GRN mutation carriers</article-title><source>Acta Neuropathologica Communications</source><volume>4</volume><elocation-id>37</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-016-0306-7</pub-id><pub-id pub-id-type="pmid">27079381</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>S</given-names></name><name><surname>Serrano</surname> <given-names>A</given-names></name><name><surname>Gerbino</surname> <given-names>V</given-names></name><name><surname>Giorgi</surname> <given-names>A</given-names></name><name><surname>Di Francesco</surname> <given-names>L</given-names></name><name><surname>Nencini</surname> <given-names>M</given-names></name><name><surname>Bozzo</surname> <given-names>F</given-names></name><name><surname>Schininà</surname> <given-names>ME</given-names></name><name><surname>Bagni</surname> <given-names>C</given-names></name><name><surname>Cestra</surname> <given-names>G</given-names></name><name><surname>Carrì</surname> <given-names>MT</given-names></name><name><surname>Achsel</surname> <given-names>T</given-names></name><name><surname>Cozzolino</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nuclear accumulation of mRNAs underlies G4C2-repeat-induced translational repression in a cellular model of C9orf72 ALS</article-title><source>Journal of Cell Science</source><volume>128</volume><fpage>1787</fpage><lpage>1799</lpage><pub-id pub-id-type="doi">10.1242/jcs.165332</pub-id><pub-id pub-id-type="pmid">25788698</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sareen</surname> <given-names>D</given-names></name><name><surname>O'Rourke</surname> <given-names>JG</given-names></name><name><surname>Meera</surname> <given-names>P</given-names></name><name><surname>Muhammad</surname> <given-names>AK</given-names></name><name><surname>Grant</surname> <given-names>S</given-names></name><name><surname>Simpkinson</surname> <given-names>M</given-names></name><name><surname>Bell</surname> <given-names>S</given-names></name><name><surname>Carmona</surname> <given-names>S</given-names></name><name><surname>Ornelas</surname> <given-names>L</given-names></name><name><surname>Sahabian</surname> <given-names>A</given-names></name><name><surname>Gendron</surname> <given-names>T</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Baughn</surname> <given-names>M</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Bennett</surname> <given-names>CF</given-names></name><name><surname>Otis</surname> <given-names>TS</given-names></name><name><surname>Svendsen</surname> <given-names>CN</given-names></name><name><surname>Baloh</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion</article-title><source>Science Translational Medicine</source><volume>5</volume><elocation-id>208ra149</elocation-id><pub-id pub-id-type="doi">10.1126/scitranslmed.3007529</pub-id><pub-id pub-id-type="pmid">24154603</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scherzinger</surname> <given-names>E</given-names></name><name><surname>Lurz</surname> <given-names>R</given-names></name><name><surname>Turmaine</surname> <given-names>M</given-names></name><name><surname>Mangiarini</surname> <given-names>L</given-names></name><name><surname>Hollenbach</surname> <given-names>B</given-names></name><name><surname>Hasenbank</surname> <given-names>R</given-names></name><name><surname>Bates</surname> <given-names>GP</given-names></name><name><surname>Davies</surname> <given-names>SW</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name><name><surname>Wanker</surname> <given-names>EE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo</article-title><source>Cell</source><volume>90</volume><fpage>549</fpage><lpage>558</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80514-0</pub-id><pub-id pub-id-type="pmid">9267034</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schludi</surname> <given-names>MH</given-names></name><name><surname>May</surname> <given-names>S</given-names></name><name><surname>Grässer</surname> <given-names>FA</given-names></name><name><surname>Rentzsch</surname> <given-names>K</given-names></name><name><surname>Kremmer</surname> <given-names>E</given-names></name><name><surname>Küpper</surname> <given-names>C</given-names></name><name><surname>Klopstock</surname> <given-names>T</given-names></name><name><surname>Arzberger</surname> <given-names>T</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><collab>German Consortium for Frontotemporal Lobar Degeneration</collab><collab>Bavarian Brain Banking Alliance</collab></person-group><year iso-8601-date="2015">2015</year><article-title>Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing</article-title><source>Acta Neuropathologica</source><volume>130</volume><fpage>537</fpage><lpage>555</lpage><pub-id pub-id-type="doi">10.1007/s00401-015-1450-z</pub-id><pub-id pub-id-type="pmid">26085200</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellier</surname> <given-names>C</given-names></name><name><surname>Campanari</surname> <given-names>ML</given-names></name><name><surname>Julie Corbier</surname> <given-names>C</given-names></name><name><surname>Gaucherot</surname> <given-names>A</given-names></name><name><surname>Kolb-Cheynel</surname> <given-names>I</given-names></name><name><surname>Oulad-Abdelghani</surname> <given-names>M</given-names></name><name><surname>Ruffenach</surname> <given-names>F</given-names></name><name><surname>Page</surname> <given-names>A</given-names></name><name><surname>Ciura</surname> <given-names>S</given-names></name><name><surname>Kabashi</surname> <given-names>E</given-names></name><name><surname>Charlet-Berguerand</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of C9ORF72 impairs autophagy and synergizes with polyQ Ataxin-2 to induce motor neuron dysfunction and cell death</article-title><source>The EMBO Journal</source><volume>35</volume><fpage>1276</fpage><lpage>1297</lpage><pub-id pub-id-type="doi">10.15252/embj.201593350</pub-id><pub-id pub-id-type="pmid">27103069</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaner</surname> <given-names>NC</given-names></name><name><surname>Lin</surname> <given-names>MZ</given-names></name><name><surname>McKeown</surname> <given-names>MR</given-names></name><name><surname>Steinbach</surname> <given-names>PA</given-names></name><name><surname>Hazelwood</surname> <given-names>KL</given-names></name><name><surname>Davidson</surname> <given-names>MW</given-names></name><name><surname>Tsien</surname> <given-names>RY</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Improving the photostability of bright monomeric orange and red fluorescent proteins</article-title><source>Nature Methods</source><volume>5</volume><fpage>545</fpage><lpage>551</lpage><pub-id pub-id-type="doi">10.1038/nmeth.1209</pub-id><pub-id pub-id-type="pmid">18454154</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>KY</given-names></name><name><surname>Mori</surname> <given-names>E</given-names></name><name><surname>Nizami</surname> <given-names>ZF</given-names></name><name><surname>Lin</surname> <given-names>Y</given-names></name><name><surname>Kato</surname> <given-names>M</given-names></name><name><surname>Xiang</surname> <given-names>S</given-names></name><name><surname>Wu</surname> <given-names>LC</given-names></name><name><surname>Ding</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Gall</surname> <given-names>JG</given-names></name><name><surname>McKnight</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Toxic PR<sub>n</sub> poly-dipeptides encoded by the <italic>C9orf72</italic> repeat expansio<sub>n</sub> block nuclear import and export</article-title><source>PNAS</source><volume>114</volume><fpage>E1111</fpage><lpage>E1117</lpage><pub-id pub-id-type="doi">10.1073/pnas.1620293114</pub-id><pub-id pub-id-type="pmid">28069952</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Staats</surname> <given-names>KA</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Chang</surname> <given-names>WH</given-names></name><name><surname>Hung</surname> <given-names>ST</given-names></name><name><surname>Hendricks</surname> <given-names>E</given-names></name><name><surname>Linares</surname> <given-names>GR</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Son</surname> <given-names>EY</given-names></name><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Kisler</surname> <given-names>K</given-names></name><name><surname>Wilkinson</surname> <given-names>B</given-names></name><name><surname>Menendez</surname> <given-names>L</given-names></name><name><surname>Sugawara</surname> <given-names>T</given-names></name><name><surname>Woolwine</surname> <given-names>P</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Cowan</surname> <given-names>MJ</given-names></name><name><surname>Ge</surname> <given-names>B</given-names></name><name><surname>Koutsodendris</surname> <given-names>N</given-names></name><name><surname>Sandor</surname> <given-names>KP</given-names></name><name><surname>Komberg</surname> <given-names>J</given-names></name><name><surname>Vangoor</surname> <given-names>VR</given-names></name><name><surname>Senthilkumar</surname> <given-names>K</given-names></name><name><surname>Hennes</surname> <given-names>V</given-names></name><name><surname>Seah</surname> <given-names>C</given-names></name><name><surname>Nelson</surname> <given-names>AR</given-names></name><name><surname>Cheng</surname> <given-names>TY</given-names></name><name><surname>Lee</surname> <given-names>SJ</given-names></name><name><surname>August</surname> <given-names>PR</given-names></name><name><surname>Chen</surname> <given-names>JA</given-names></name><name><surname>Wisniewski</surname> <given-names>N</given-names></name><name><surname>Hanson-Smith</surname> <given-names>V</given-names></name><name><surname>Belgard</surname> <given-names>TG</given-names></name><name><surname>Zhang</surname> <given-names>A</given-names></name><name><surname>Coba</surname> <given-names>M</given-names></name><name><surname>Grunseich</surname> <given-names>C</given-names></name><name><surname>Ward</surname> <given-names>ME</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name><name><surname>Trotti</surname> <given-names>D</given-names></name><name><surname>Zlokovic</surname> <given-names>BV</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons</article-title><source>Nature Medicine</source><volume>24</volume><fpage>313</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1038/nm.4490</pub-id><pub-id pub-id-type="pmid">29400714</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simón-Sánchez</surname> <given-names>J</given-names></name><name><surname>Dopper</surname> <given-names>EG</given-names></name><name><surname>Cohn-Hokke</surname> <given-names>PE</given-names></name><name><surname>Hukema</surname> <given-names>RK</given-names></name><name><surname>Nicolaou</surname> <given-names>N</given-names></name><name><surname>Seelaar</surname> <given-names>H</given-names></name><name><surname>de Graaf</surname> <given-names>JR</given-names></name><name><surname>de Koning</surname> <given-names>I</given-names></name><name><surname>van Schoor</surname> <given-names>NM</given-names></name><name><surname>Deeg</surname> <given-names>DJ</given-names></name><name><surname>Smits</surname> <given-names>M</given-names></name><name><surname>Raaphorst</surname> <given-names>J</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Schelhaas</surname> <given-names>HJ</given-names></name><name><surname>De Die-Smulders</surname> <given-names>CE</given-names></name><name><surname>Majoor-Krakauer</surname> <given-names>D</given-names></name><name><surname>Rozemuller</surname> <given-names>AJ</given-names></name><name><surname>Willemsen</surname> <given-names>R</given-names></name><name><surname>Pijnenburg</surname> <given-names>YA</given-names></name><name><surname>Heutink</surname> <given-names>P</given-names></name><name><surname>van Swieten</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions</article-title><source>Brain</source><volume>135</volume><fpage>723</fpage><lpage>735</lpage><pub-id pub-id-type="doi">10.1093/brain/awr353</pub-id><pub-id pub-id-type="pmid">22300876</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slomnicki</surname> <given-names>LP</given-names></name><name><surname>Pietrzak</surname> <given-names>M</given-names></name><name><surname>Vashishta</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>J</given-names></name><name><surname>Lynch</surname> <given-names>N</given-names></name><name><surname>Elliot</surname> <given-names>S</given-names></name><name><surname>Poulos</surname> <given-names>E</given-names></name><name><surname>Malicote</surname> <given-names>D</given-names></name><name><surname>Morris</surname> <given-names>BE</given-names></name><name><surname>Hallgren</surname> <given-names>J</given-names></name><name><surname>Hetman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Requirement of neuronal ribosome synthesis for growth and maintenance of the dendritic tree</article-title><source>Journal of Biological Chemistry</source><volume>291</volume><fpage>5721</fpage><lpage>5739</lpage><pub-id pub-id-type="doi">10.1074/jbc.M115.682161</pub-id><pub-id pub-id-type="pmid">26757818</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Solomon</surname> <given-names>DA</given-names></name><name><surname>Stepto</surname> <given-names>A</given-names></name><name><surname>Au</surname> <given-names>WH</given-names></name><name><surname>Adachi</surname> <given-names>Y</given-names></name><name><surname>Diaper</surname> <given-names>DC</given-names></name><name><surname>Hall</surname> <given-names>R</given-names></name><name><surname>Rekhi</surname> <given-names>A</given-names></name><name><surname>Boudi</surname> <given-names>A</given-names></name><name><surname>Tziortzouda</surname> <given-names>P</given-names></name><name><surname>Lee</surname> <given-names>YB</given-names></name><name><surname>Smith</surname> <given-names>B</given-names></name><name><surname>Bridi</surname> <given-names>JC</given-names></name><name><surname>Spinelli</surname> <given-names>G</given-names></name><name><surname>Dearlove</surname> <given-names>J</given-names></name><name><surname>Humphrey</surname> <given-names>DM</given-names></name><name><surname>Gallo</surname> <given-names>JM</given-names></name><name><surname>Troakes</surname> <given-names>C</given-names></name><name><surname>Fanto</surname> <given-names>M</given-names></name><name><surname>Soller</surname> <given-names>M</given-names></name><name><surname>Rogelj</surname> <given-names>B</given-names></name><name><surname>Parsons</surname> <given-names>RB</given-names></name><name><surname>Shaw</surname> <given-names>CE</given-names></name><name><surname>Hortobágyi</surname> <given-names>T</given-names></name><name><surname>Hirth</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration</article-title><source>Brain</source><volume>141</volume><fpage>2908</fpage><lpage>2924</lpage><pub-id pub-id-type="doi">10.1093/brain/awy241</pub-id><pub-id pub-id-type="pmid">30239641</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudria-Lopez</surname> <given-names>E</given-names></name><name><surname>Koppers</surname> <given-names>M</given-names></name><name><surname>de Wit</surname> <given-names>M</given-names></name><name><surname>van der Meer</surname> <given-names>C</given-names></name><name><surname>Westeneng</surname> <given-names>HJ</given-names></name><name><surname>Zundel</surname> <given-names>CA</given-names></name><name><surname>Youssef</surname> <given-names>SA</given-names></name><name><surname>Harkema</surname> <given-names>L</given-names></name><name><surname>de Bruin</surname> <given-names>A</given-names></name><name><surname>Veldink</surname> <given-names>JH</given-names></name><name><surname>van den Berg</surname> <given-names>LH</given-names></name><name><surname>Pasterkamp</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Full ablation of C9orf72 in mice causes immune system-related pathology and neoplastic events but no motor neuron defects</article-title><source>Acta Neuropathologica</source><volume>132</volume><fpage>145</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1007/s00401-016-1581-x</pub-id><pub-id pub-id-type="pmid">27206760</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname> <given-names>PM</given-names></name><name><surname>Zhou</surname> <given-names>X</given-names></name><name><surname>Robins</surname> <given-names>AM</given-names></name><name><surname>Paushter</surname> <given-names>DH</given-names></name><name><surname>Kim</surname> <given-names>D</given-names></name><name><surname>Smolka</surname> <given-names>MB</given-names></name><name><surname>Hu</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway</article-title><source>Acta Neuropathologica Communications</source><volume>4</volume><elocation-id>51</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-016-0324-5</pub-id><pub-id pub-id-type="pmid">27193190</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname> <given-names>N</given-names></name><name><surname>Maroof</surname> <given-names>AM</given-names></name><name><surname>Merkle</surname> <given-names>FT</given-names></name><name><surname>Koszka</surname> <given-names>K</given-names></name><name><surname>Intoh</surname> <given-names>A</given-names></name><name><surname>Armstrong</surname> <given-names>I</given-names></name><name><surname>Moccia</surname> <given-names>R</given-names></name><name><surname>Davis-Dusenbery</surname> <given-names>BN</given-names></name><name><surname>Eggan</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The mouse C9ORF72 ortholog is enriched in neurons known to degenerate in ALS and FTD</article-title><source>Nature Neuroscience</source><volume>16</volume><fpage>1725</fpage><lpage>1727</lpage><pub-id pub-id-type="doi">10.1038/nn.3566</pub-id><pub-id pub-id-type="pmid">24185425</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swinnen</surname> <given-names>B</given-names></name><name><surname>Bento-Abreu</surname> <given-names>A</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Bogaert</surname> <given-names>E</given-names></name><name><surname>Nuyts</surname> <given-names>R</given-names></name><name><surname>Timmers</surname> <given-names>M</given-names></name><name><surname>Scheveneels</surname> <given-names>W</given-names></name><name><surname>Hersmus</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Mizielinska</surname> <given-names>S</given-names></name><name><surname>Isaacs</surname> <given-names>AM</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Lemmens</surname> <given-names>R</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name><name><surname>Robberecht</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism</article-title><source>Acta Neuropathologica</source><volume>135</volume><fpage>427</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1007/s00401-017-1796-5</pub-id><pub-id pub-id-type="pmid">29302778</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname> <given-names>Z</given-names></name><name><surname>Wang</surname> <given-names>H</given-names></name><name><surname>Xia</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Li</surname> <given-names>K</given-names></name><name><surname>Jiang</surname> <given-names>X</given-names></name><name><surname>Xu</surname> <given-names>G</given-names></name><name><surname>Wang</surname> <given-names>G</given-names></name><name><surname>Ying</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>2426</fpage><lpage>2441</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddv005</pub-id><pub-id pub-id-type="pmid">25575510</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tran</surname> <given-names>H</given-names></name><name><surname>Almeida</surname> <given-names>S</given-names></name><name><surname>Moore</surname> <given-names>J</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Chalasani</surname> <given-names>U</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Du</surname> <given-names>X</given-names></name><name><surname>Nickerson</surname> <given-names>JA</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Weng</surname> <given-names>Z</given-names></name><name><surname>Gao</surname> <given-names>FB</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Differential toxicity of nuclear RNA foci versus dipeptide repeat proteins in a <italic>Drosophila</italic> model of C9ORF72 FTD/ALS</article-title><source>Neuron</source><volume>87</volume><fpage>1207</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2015.09.015</pub-id><pub-id pub-id-type="pmid">26402604</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ugolino</surname> <given-names>J</given-names></name><name><surname>Ji</surname> <given-names>YJ</given-names></name><name><surname>Conchina</surname> <given-names>K</given-names></name><name><surname>Chu</surname> <given-names>J</given-names></name><name><surname>Nirujogi</surname> <given-names>RS</given-names></name><name><surname>Pandey</surname> <given-names>A</given-names></name><name><surname>Brady</surname> <given-names>NR</given-names></name><name><surname>Hamacher-Brady</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Loss of C9orf72 enhances autophagic activity via deregulated mTOR and TFEB signaling</article-title><source>PLOS Genetics</source><volume>12</volume><elocation-id>e1006443</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1006443</pub-id><pub-id pub-id-type="pmid">27875531</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanneste</surname> <given-names>J</given-names></name><name><surname>Vercruysse</surname> <given-names>T</given-names></name><name><surname>Boeynaems</surname> <given-names>S</given-names></name><name><surname>Sicart</surname> <given-names>A</given-names></name><name><surname>Van Damme</surname> <given-names>P</given-names></name><name><surname>Daelemans</surname> <given-names>D</given-names></name><name><surname>Van Den Bosch</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9orf72-generated poly-GR and poly-PR do not directly interfere with nucleocytoplasmic transport</article-title><source>Scientific Reports</source><volume>9</volume><elocation-id>15728</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-019-52035-6</pub-id><pub-id pub-id-type="pmid">31673013</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vincenz-Donnelly</surname> <given-names>L</given-names></name><name><surname>Holthusen</surname> <given-names>H</given-names></name><name><surname>Körner</surname> <given-names>R</given-names></name><name><surname>Hansen</surname> <given-names>EC</given-names></name><name><surname>Presto</surname> <given-names>J</given-names></name><name><surname>Johansson</surname> <given-names>J</given-names></name><name><surname>Sawarkar</surname> <given-names>R</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidogenic proteins</article-title><source>The EMBO Journal</source><volume>37</volume><fpage>337</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.15252/embj.201695841</pub-id><pub-id pub-id-type="pmid">29247078</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waite</surname> <given-names>AJ</given-names></name><name><surname>Bäumer</surname> <given-names>D</given-names></name><name><surname>East</surname> <given-names>S</given-names></name><name><surname>Neal</surname> <given-names>J</given-names></name><name><surname>Morris</surname> <given-names>HR</given-names></name><name><surname>Ansorge</surname> <given-names>O</given-names></name><name><surname>Blake</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion</article-title><source>Neurobiology of Aging</source><volume>35</volume><elocation-id>1779.e5</elocation-id><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2014.01.016</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanker</surname> <given-names>EE</given-names></name><name><surname>Scherzinger</surname> <given-names>E</given-names></name><name><surname>Heiser</surname> <given-names>V</given-names></name><name><surname>Sittler</surname> <given-names>A</given-names></name><name><surname>Eickhoff</surname> <given-names>H</given-names></name><name><surname>Lehrach</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Membrane filter assay for detection of amyloid-like polyglutamine-containing protein aggregates</article-title><source>Methods in Enzymology</source><volume>309</volume><fpage>375</fpage><lpage>386</lpage><pub-id pub-id-type="doi">10.1016/s0076-6879(99)09026-6</pub-id><pub-id pub-id-type="pmid">10507036</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname> <given-names>X</given-names></name><name><surname>Tan</surname> <given-names>W</given-names></name><name><surname>Westergard</surname> <given-names>T</given-names></name><name><surname>Krishnamurthy</surname> <given-names>K</given-names></name><name><surname>Markandaiah</surname> <given-names>SS</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Lin</surname> <given-names>S</given-names></name><name><surname>Shneider</surname> <given-names>NA</given-names></name><name><surname>Monaghan</surname> <given-names>J</given-names></name><name><surname>Pandey</surname> <given-names>UB</given-names></name><name><surname>Pasinelli</surname> <given-names>P</given-names></name><name><surname>Ichida</surname> <given-names>JK</given-names></name><name><surname>Trotti</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death</article-title><source>Neuron</source><volume>84</volume><fpage>1213</fpage><lpage>1225</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.010</pub-id><pub-id pub-id-type="pmid">25521377</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname> <given-names>MW</given-names></name><name><surname>Wang</surname> <given-names>W</given-names></name><name><surname>Patterson</surname> <given-names>J</given-names></name><name><surname>Mancias</surname> <given-names>JD</given-names></name><name><surname>Beasley</surname> <given-names>JR</given-names></name><name><surname>Hecht</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>De novo amyloid proteins from designed combinatorial libraries</article-title><source>PNAS</source><volume>96</volume><fpage>11211</fpage><lpage>11216</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.20.11211</pub-id><pub-id pub-id-type="pmid">10500156</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>West</surname> <given-names>RJH</given-names></name><name><surname>Sharpe</surname> <given-names>JL</given-names></name><name><surname>Voelzmann</surname> <given-names>A</given-names></name><name><surname>Munro</surname> <given-names>AL</given-names></name><name><surname>Hahn</surname> <given-names>I</given-names></name><name><surname>Baines</surname> <given-names>RA</given-names></name><name><surname>Pickering-Brown</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Co-expression of C9orf72 related dipeptide-repeats over 1000 repeat units reveals age- and combination-specific phenotypic profiles in <italic>Drosophila</italic></article-title><source>Acta Neuropathologica Communications</source><volume>8</volume><elocation-id>158</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-020-01028-y</pub-id><pub-id pub-id-type="pmid">32894207</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>White</surname> <given-names>MR</given-names></name><name><surname>Mitrea</surname> <given-names>DM</given-names></name><name><surname>Zhang</surname> <given-names>P</given-names></name><name><surname>Stanley</surname> <given-names>CB</given-names></name><name><surname>Cassidy</surname> <given-names>DE</given-names></name><name><surname>Nourse</surname> <given-names>A</given-names></name><name><surname>Phillips</surname> <given-names>AH</given-names></name><name><surname>Tolbert</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Kriwacki</surname> <given-names>RW</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C9orf72 poly(PR) Dipeptide repeats disturb biomolecular phase separation and disrupt nucleolar function</article-title><source>Molecular Cell</source><volume>74</volume><fpage>713</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2019.03.019</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woerner</surname> <given-names>AC</given-names></name><name><surname>Frottin</surname> <given-names>F</given-names></name><name><surname>Hornburg</surname> <given-names>D</given-names></name><name><surname>Feng</surname> <given-names>LR</given-names></name><name><surname>Meissner</surname> <given-names>F</given-names></name><name><surname>Patra</surname> <given-names>M</given-names></name><name><surname>Tatzelt</surname> <given-names>J</given-names></name><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Winklhofer</surname> <given-names>KF</given-names></name><name><surname>Hartl</surname> <given-names>FU</given-names></name><name><surname>Hipp</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cytoplasmic protein aggregates interfere with nucleocytoplasmic transport of protein and RNA</article-title><source>Science</source><volume>351</volume><fpage>173</fpage><lpage>176</lpage><pub-id pub-id-type="doi">10.1126/science.aad2033</pub-id><pub-id pub-id-type="pmid">26634439</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolff</surname> <given-names>B</given-names></name><name><surname>Sanglier</surname> <given-names>JJ</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA</article-title><source>Chemistry &amp; Biology</source><volume>4</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/S1074-5521(97)90257-X</pub-id><pub-id pub-id-type="pmid">9190288</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Z</given-names></name><name><surname>Poidevin</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Shu</surname> <given-names>L</given-names></name><name><surname>Nelson</surname> <given-names>DL</given-names></name><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Hales</surname> <given-names>CM</given-names></name><name><surname>Gearing</surname> <given-names>M</given-names></name><name><surname>Wingo</surname> <given-names>TS</given-names></name><name><surname>Jin</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration</article-title><source>PNAS</source><volume>110</volume><fpage>7778</fpage><lpage>7783</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219643110</pub-id><pub-id pub-id-type="pmid">23553836</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamakawa</surname> <given-names>M</given-names></name><name><surname>Ito</surname> <given-names>D</given-names></name><name><surname>Honda</surname> <given-names>T</given-names></name><name><surname>Kubo</surname> <given-names>K</given-names></name><name><surname>Noda</surname> <given-names>M</given-names></name><name><surname>Nakajima</surname> <given-names>K</given-names></name><name><surname>Suzuki</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS</article-title><source>Human Molecular Genetics</source><volume>24</volume><fpage>1630</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddu576</pub-id><pub-id pub-id-type="pmid">25398948</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Liang</surname> <given-names>C</given-names></name><name><surname>Swaminathan</surname> <given-names>K</given-names></name><name><surname>Herrlinger</surname> <given-names>S</given-names></name><name><surname>Lai</surname> <given-names>F</given-names></name><name><surname>Shiekhattar</surname> <given-names>R</given-names></name><name><surname>Chen</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy</article-title><source>Science Advances</source><volume>2</volume><elocation-id>e1601167</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.1601167</pub-id><pub-id pub-id-type="pmid">27617292</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>YF</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Bieniek</surname> <given-names>KF</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Sasaguri</surname> <given-names>H</given-names></name><name><surname>Caulfield</surname> <given-names>T</given-names></name><name><surname>Hubbard</surname> <given-names>J</given-names></name><name><surname>Daughrity</surname> <given-names>L</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Belzil</surname> <given-names>VV</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Stankowski</surname> <given-names>JN</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Whitelaw</surname> <given-names>E</given-names></name><name><surname>Ash</surname> <given-names>PE</given-names></name><name><surname>DeTure</surname> <given-names>M</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress</article-title><source>Acta Neuropathologica</source><volume>128</volume><fpage>505</fpage><lpage>524</lpage><pub-id pub-id-type="doi">10.1007/s00401-014-1336-5</pub-id><pub-id pub-id-type="pmid">25173361</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Donnelly</surname> <given-names>CJ</given-names></name><name><surname>Haeusler</surname> <given-names>AR</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Machamer</surname> <given-names>JB</given-names></name><name><surname>Steinwald</surname> <given-names>P</given-names></name><name><surname>Daley</surname> <given-names>EL</given-names></name><name><surname>Miller</surname> <given-names>SJ</given-names></name><name><surname>Cunningham</surname> <given-names>KM</given-names></name><name><surname>Vidensky</surname> <given-names>S</given-names></name><name><surname>Gupta</surname> <given-names>S</given-names></name><name><surname>Thomas</surname> <given-names>MA</given-names></name><name><surname>Hong</surname> <given-names>I</given-names></name><name><surname>Chiu</surname> <given-names>SL</given-names></name><name><surname>Huganir</surname> <given-names>RL</given-names></name><name><surname>Ostrow</surname> <given-names>LW</given-names></name><name><surname>Matunis</surname> <given-names>MJ</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sattler</surname> <given-names>R</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The C9orf72 repeat expansion disrupts nucleocytoplasmic transport</article-title><source>Nature</source><volume>525</volume><fpage>56</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1038/nature14973</pub-id><pub-id pub-id-type="pmid">26308891</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Sasaguri</surname> <given-names>H</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Xu</surname> <given-names>YF</given-names></name><name><surname>Katzman</surname> <given-names>RB</given-names></name><name><surname>Gass</surname> <given-names>J</given-names></name><name><surname>Murray</surname> <given-names>ME</given-names></name><name><surname>Shinohara</surname> <given-names>M</given-names></name><name><surname>Lin</surname> <given-names>WL</given-names></name><name><surname>Garrett</surname> <given-names>A</given-names></name><name><surname>Stankowski</surname> <given-names>JN</given-names></name><name><surname>Daughrity</surname> <given-names>L</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Perkerson</surname> <given-names>EA</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>ZS</given-names></name><name><surname>Liesinger</surname> <given-names>AM</given-names></name><name><surname>Baker</surname> <given-names>JD</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Edbauer</surname> <given-names>D</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Boylan</surname> <given-names>KB</given-names></name><name><surname>Bu</surname> <given-names>G</given-names></name><name><surname>Link</surname> <given-names>CD</given-names></name><name><surname>Dickey</surname> <given-names>CA</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9ORF72 poly(GA) aggregates sequester and impair HR23 and nucleocytoplasmic transport proteins</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>668</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1038/nn.4272</pub-id><pub-id pub-id-type="pmid">26998601</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>K</given-names></name><name><surname>Daigle</surname> <given-names>JG</given-names></name><name><surname>Cunningham</surname> <given-names>KM</given-names></name><name><surname>Coyne</surname> <given-names>AN</given-names></name><name><surname>Ruan</surname> <given-names>K</given-names></name><name><surname>Grima</surname> <given-names>JC</given-names></name><name><surname>Bowen</surname> <given-names>KE</given-names></name><name><surname>Wadhwa</surname> <given-names>H</given-names></name><name><surname>Yang</surname> <given-names>P</given-names></name><name><surname>Rigo</surname> <given-names>F</given-names></name><name><surname>Taylor</surname> <given-names>JP</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Lloyd</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2018">2018a</year><article-title>Stress granule assembly disrupts nucleocytoplasmic transport</article-title><source>Cell</source><volume>173</volume><fpage>958</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.03.025</pub-id><pub-id pub-id-type="pmid">29628143</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>YJ</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>Ebbert</surname> <given-names>MTW</given-names></name><name><surname>O'Raw</surname> <given-names>AD</given-names></name><name><surname>Yue</surname> <given-names>M</given-names></name><name><surname>Jansen-West</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Prudencio</surname> <given-names>M</given-names></name><name><surname>Chew</surname> <given-names>J</given-names></name><name><surname>Cook</surname> <given-names>CN</given-names></name><name><surname>Daughrity</surname> <given-names>LM</given-names></name><name><surname>Tong</surname> <given-names>J</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name><name><surname>Pickles</surname> <given-names>SR</given-names></name><name><surname>Castanedes-Casey</surname> <given-names>M</given-names></name><name><surname>Kurti</surname> <given-names>A</given-names></name><name><surname>Rademakers</surname> <given-names>R</given-names></name><name><surname>Oskarsson</surname> <given-names>B</given-names></name><name><surname>Dickson</surname> <given-names>DW</given-names></name><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Gitler</surname> <given-names>AD</given-names></name><name><surname>Fryer</surname> <given-names>JD</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018b</year><article-title>Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis</article-title><source>Nature Medicine</source><volume>24</volume><fpage>1136</fpage><lpage>1142</lpage><pub-id pub-id-type="doi">10.1038/s41591-018-0071-1</pub-id><pub-id pub-id-type="pmid">29942091</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname> <given-names>Q</given-names></name><name><surname>Jiang</surname> <given-names>J</given-names></name><name><surname>Gendron</surname> <given-names>TF</given-names></name><name><surname>McAlonis-Downes</surname> <given-names>M</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Taylor</surname> <given-names>A</given-names></name><name><surname>Diaz Garcia</surname> <given-names>S</given-names></name><name><surname>Ghosh Dastidar</surname> <given-names>S</given-names></name><name><surname>Rodriguez</surname> <given-names>MJ</given-names></name><name><surname>King</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name><name><surname>Xu</surname> <given-names>H</given-names></name><name><surname>Petrucelli</surname> <given-names>L</given-names></name><name><surname>Ravits</surname> <given-names>J</given-names></name><name><surname>Da Cruz</surname> <given-names>S</given-names></name><name><surname>Lagier-Tourenne</surname> <given-names>C</given-names></name><name><surname>Cleveland</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>615</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/s41593-020-0619-5</pub-id><pub-id pub-id-type="pmid">32284607</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Bañez-Coronel</surname> <given-names>M</given-names></name><name><surname>Reid</surname> <given-names>T</given-names></name><name><surname>Pletnikova</surname> <given-names>O</given-names></name><name><surname>Lewis</surname> <given-names>J</given-names></name><name><surname>Miller</surname> <given-names>TM</given-names></name><name><surname>Harms</surname> <given-names>MB</given-names></name><name><surname>Falchook</surname> <given-names>AE</given-names></name><name><surname>Subramony</surname> <given-names>SH</given-names></name><name><surname>Ostrow</surname> <given-names>LW</given-names></name><name><surname>Rothstein</surname> <given-names>JD</given-names></name><name><surname>Troncoso</surname> <given-names>JC</given-names></name><name><surname>Ranum</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia</article-title><source>PNAS</source><volume>110</volume><fpage>E4968</fpage><lpage>E4977</lpage><pub-id pub-id-type="doi">10.1073/pnas.1315438110</pub-id><pub-id pub-id-type="pmid">24248382</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.62718.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Ackerman</surname><given-names>Susan L</given-names></name><role>Reviewing Editor</role><aff><institution>Howard Hughes Medical Institute, University of California, San Diego</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>A G4C2 repeat expansion in the C9orf72 gene causes amyotrophic lateral sclerosis and frontotemporal dementia. This work evaluates the relative contributions of dipeptide repeat proteins (DPR) and the repeat-containing mRNA derived from this repeat expansion in toxicity in a cellular model. Findings demonstrate that the G4C2 RNA is sufficient to reduce viability and inhibit nuclear transport in this model, and that the encoded DPR-containing proteins further contribute in an additive fashion to the toxic gain of function of this repeat expansion.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Multiple pathways of toxicity induced by C9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 3 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by David Ron as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>The discovery in 2011 that a hexanucleotide (G4C2) expansion in the C9orf72 gene is the most frequent cause of inherited ALS and frontal temporal dementia has fuelled many reports testing whether slow, age-dependent dysfunction, degeneration, and ultimately death of selected classes of neurons is caused by G4C2 repeat containing RNAs (encoded by either sense or antisense DNA strands and accumulated into nuclear RNA foci) or by one or more of their five encoded dipeptide repeat polypeptides (DPRs) translated in an AUG independent manner. Multiple prior reports have reported evidence of toxicity of specific DPRs, several have argued for RNA-mediated toxicity, and several have argued for toxicity from both. Using synthetic genes that encode cytoplasmic or nuclear poly(65) GA aggregates in the absence of G4C2 hexanucleotide repeats, the authors demonstrate that the cellular compartment of polyGA aggregates is associated with specific aspects of cellular dysfunction (e.g., nuclear (but non-nucleolar) aggregates interfered with the protein quality control function of the nucleolus and cytoplasmic aggregates partially inhibited transport of proteins across the nuclear pore). However, expression of the G4C2 RNA, rather than DPRs, was associated with a decrease in cellular viability. Together these experiments demonstrate that DPRs and G4C2 RNA toxicity both impinge on cellular function/viability, likely in an additive fashion.</p><p>While all reviewers agreed that the quality of the studies is very high, there was extensive discussion about the direct relevance of these studies to ALS due to the single test system used – expression by transient transfection in HEK293T cells of a short (65 or 73) repeat. This system has very significant weaknesses that may preclude strong conclusions that go beyond the weaknesses of the prior work. These include: the cells are rapidly cycling; the level of expression relative to that in the neurons at risk in ALS or FTD is not determined; the repeats are far, far shorter than in the affected regions of the human nervous system where the repeat lengths are heterogeneous but in the many hundreds to many thousands; the properties of the short DPRs or RNAs are highly uncertain to reflect the levels and lengths of the corresponding DPRs or RNAs in human disease; there is no evidence that suggests that the lessons in these cycling, non-neuronal cells reflect the age-dependent selective damage within the neurons in human disease; and the viability assay does not uniquely distinguish inhibited cell cycling from cell death and is measured at 4 days, rather than the time scale of years that would be reflective of human disease.</p><p>While these weaknesses are also weaknesses of most of the preceding work, their limitations strongly reduce the novelty and success of the current work in setting it apart from the many prior reports. In addition, the reviewers felt that the previous studies on C9orf72 DPRs and/or RNA repeat toxicity were often superficially cited and citations of some recent publications were omitted. For further consideration, the authors are requested to re-examine the manuscript, in particular the introduction and discussion, to ensure that the reader can clearly understand the findings of previous studies so that the context is set for the current study. In addition, the authors are strongly urged to clearly define the relevance of their study in light of the points above.</p><p>Additional points for revision:</p><p>1. In Figure 1-supplement 1B, I do not see the peripheral staining with anti-amyloid antibody (OC) on the cytoplasmic inclusion. Is this image representative? If so, perhaps the authors can tone down this conclusion.</p><p>2. What is Beta23 in Figure 2D and Figure 2 supplement 1B?</p><p>3. In Figure 4-supplement 1C, the importin inclusions/sequestration of importin Beta-1 is not clear, particularly relative to the images in A and B? Perhaps the authors can comment on this in the text or show better images?</p><p>4. Representative images for protein translation experiments should be shown in Figure 5D for comparison to quantitated values.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.62718.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>The discovery in 2011 that a hexanucleotide (G4C2) expansion in the C9orf72 gene is the most frequent cause of inherited ALS and frontal temporal dementia has fuelled many reports testing whether slow, age-dependent dysfunction, degeneration, and ultimately death of selected classes of neurons is caused by G4C2 repeat containing RNAs (encoded by either sense or antisense DNA strands and accumulated into nuclear RNA foci) or by one or more of their five encoded dipeptide repeat polypeptides (DPRs) translated in an AUG independent manner. Multiple prior reports have reported evidence of toxicity of specific DPRs, several have argued for RNA-mediated toxicity, and several have argued for toxicity from both. Using synthetic genes that encode cytoplasmic or nuclear poly(65) GA aggregates in the absence of G4C2 hexanucleotide repeats, the authors demonstrate that the cellular compartment of polyGA aggregates is associated with specific aspects of cellular dysfunction (e.g., nuclear (but non-nucleolar) aggregates interfered with the protein quality control function of the nucleolus and cytoplasmic aggregates partially inhibited transport of proteins across the nuclear pore). However, expression of the G4C2 RNA, rather than DPRs, was associated with a decrease in cellular viability. Together these experiments demonstrate that DPRs and G4C2 RNA toxicity both impinge on cellular function/viability, likely in an additive fashion.</p><p>While all reviewers agreed that the quality of the studies is very high, there was extensive discussion about the direct relevance of these studies to ALS due to the single test system used – expression by transient transfection in HEK293T cells of a short (65 or 73) repeat. This system has very significant weaknesses that may preclude strong conclusions that go beyond the weaknesses of the prior work. These include: the cells are rapidly cycling; the level of expression relative to that in the neurons at risk in ALS or FTD is not determined; the repeats are far, far shorter than in the affected regions of the human nervous system where the repeat lengths are heterogeneous but in the many hundreds to many thousands; the properties of the short DPRs or RNAs are highly uncertain to reflect the levels and lengths of the corresponding DPRs or RNAs in human disease; there is no evidence that suggests that the lessons in these cycling, non-neuronal cells reflect the age-dependent selective damage within the neurons in human disease; and the viability assay does not uniquely distinguish inhibited cell cycling from cell death and is measured at 4 days, rather than the time scale of years that would be reflective of human disease.</p><p>While these weaknesses are also weaknesses of most of the preceding work, their limitations strongly reduce the novelty and success of the current work in setting it apart from the many prior reports. In addition, the reviewers felt that the previous studies on C9orf72 DPRs and/or RNA repeat toxicity were often superficially cited and citations of some recent publications were omitted. For further consideration, the authors are requested to re-examine the manuscript, in particular the introduction and discussion, to ensure that the reader can clearly understand the findings of previous studies so that the context is set for the current study. In addition, the authors are strongly urged to clearly define the relevance of their study in light of the points above.</p></disp-quote><p>We thank the reviewers for their helpful comments.</p><p>We have rewritten the introduction and the discussion and added a series of additional references to provide more context. We now state explicitly that we work in a cellular system (including in the title, the abstract, the introduction, the Results section and the discussion) and refer to the differences between the localization of arginine containing aggregates in cellular systems and patient material in the introduction and the discussion.</p><p>We would like to stress that our C9orf72 constructs recapitulate many features observed in patient samples, such as the formation of p62 positive cytoplasmic poly-GA inclusions and of nuclear G<sub>4</sub>C<sub>2</sub>-containing RNA foci. A critical advantage of the cellular system used is the fact that targeting poly-GA to the cytosol (NES-polyGA) does not result in overt toxicity. As a result, we can now (for the first time) clearly distinguish between G<sub>4</sub>C<sub>2</sub> mRNA toxicity and proteotoxicity. We have emphasized this point in the revised manuscript.</p><p>However, we have also discussed the limitations of the cellular model system more extensively and state in the revised manuscript that “the longer G<sub>4</sub>C<sub>2</sub> expansions, and the resulting DPRs, present in patients may have additional adverse effects that were not recapitulated with the constructs used here” , that “longer G<sub>4</sub>C<sub>2</sub> sequences may mediate additional effects (West et al., 2020)” and that “we cannot exclude a DPR contribution to pathology in carriers of G<sub>4</sub>C<sub>2</sub> expansions, where combinations of the various DPRs and mRNA are present simultaneously, and nondividing cells are exposed to these factors for extended time periods”. Notwithstanding these limitations, we demonstrate that the toxicity exerted by the repeat mRNA is substantially stronger when comparing constructs of the same length.</p><p>We hope that with these changes we have addressed the general concerns raised by the reviewers.</p><disp-quote content-type="editor-comment"><p>Additional points for revision:</p><p>1. In Figure 1-supplement 1B, I do not see the peripheral staining with anti-amyloid antibody (OC) on the cytoplasmic inclusion. Is this image representative? If so, perhaps the authors can tone down this conclusion.</p></disp-quote><p>We have rephrased this statement and exchanged the image with an example where the peripheral staining is better visible.</p><disp-quote content-type="editor-comment"><p>2. What is Beta23 in Figure 2D and Figure 2 supplement 1B?</p></disp-quote><p>Beta23 is an aggregation-prone beta-sheet protein. We are using it to control for compartment specific toxic effects of protein aggregation. This is now explained and appropriate references have been added (Woerner et al. 2016, and West et al. 1999)</p><disp-quote content-type="editor-comment"><p>3. In Figure 4-supplement 1C, the importin inclusions/sequestration of importin Beta-1 is not clear, particularly relative to the images in A and B? Perhaps the authors can comment on this in the text or show better images?</p></disp-quote><p>We have altered the text to emphasize that the effect for KPNA2 and KPNA4 is stronger than for KPNB1, and have added fluorescence profiles to Figure 4-supp1C to show the elevated levels of the importins more clearly.</p><disp-quote content-type="editor-comment"><p>4. Representative images for protein translation experiments should be shown in Figure 5D for comparison to quantitated values.</p></disp-quote><p>We have now moved the examples for the quantification of the experiment from Supplementary figure 5D to the main Figure 5.</p></body></sub-article></article>